ZA200108768B - Herbicide resistant plants. - Google Patents
Herbicide resistant plants. Download PDFInfo
- Publication number
- ZA200108768B ZA200108768B ZA200108768A ZA200108768A ZA200108768B ZA 200108768 B ZA200108768 B ZA 200108768B ZA 200108768 A ZA200108768 A ZA 200108768A ZA 200108768 A ZA200108768 A ZA 200108768A ZA 200108768 B ZA200108768 B ZA 200108768B
- Authority
- ZA
- South Africa
- Prior art keywords
- polynucleotide
- epsps
- enhancer
- sequence
- rice
- Prior art date
Links
- 239000004009 herbicide Substances 0.000 title claims description 41
- 230000002363 herbicidal effect Effects 0.000 title claims description 34
- 241000196324 Embryophyta Species 0.000 claims description 172
- 240000007594 Oryza sativa Species 0.000 claims description 136
- 235000007164 Oryza sativa Nutrition 0.000 claims description 134
- 235000009566 rice Nutrition 0.000 claims description 131
- 108091033319 polynucleotide Proteins 0.000 claims description 103
- 102000040430 polynucleotide Human genes 0.000 claims description 103
- 239000002157 polynucleotide Substances 0.000 claims description 103
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 claims description 85
- 108020004414 DNA Proteins 0.000 claims description 80
- 239000003623 enhancer Substances 0.000 claims description 79
- 238000000034 method Methods 0.000 claims description 73
- 239000000463 material Substances 0.000 claims description 67
- 239000013598 vector Substances 0.000 claims description 63
- 239000005562 Glyphosate Substances 0.000 claims description 59
- 229940097068 glyphosate Drugs 0.000 claims description 59
- 108090000623 proteins and genes Proteins 0.000 claims description 55
- 240000008042 Zea mays Species 0.000 claims description 50
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 50
- 230000014509 gene expression Effects 0.000 claims description 50
- 210000002257 embryonic structure Anatomy 0.000 claims description 49
- 210000001519 tissue Anatomy 0.000 claims description 46
- 241000589158 Agrobacterium Species 0.000 claims description 45
- 150000003839 salts Chemical class 0.000 claims description 45
- 230000009466 transformation Effects 0.000 claims description 44
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 42
- 238000011144 upstream manufacturing Methods 0.000 claims description 41
- 239000002773 nucleotide Substances 0.000 claims description 37
- 125000003729 nucleotide group Chemical group 0.000 claims description 37
- 102000004169 proteins and genes Human genes 0.000 claims description 30
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 29
- 235000009973 maize Nutrition 0.000 claims description 29
- 230000002103 transcriptional effect Effects 0.000 claims description 29
- 101150111720 EPSPS gene Proteins 0.000 claims description 23
- 239000002245 particle Substances 0.000 claims description 23
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 21
- 235000005822 corn Nutrition 0.000 claims description 21
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 19
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 18
- 240000005979 Hordeum vulgare Species 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 17
- 241000209140 Triticum Species 0.000 claims description 17
- 108020004705 Codon Proteins 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 16
- 235000021307 Triticum Nutrition 0.000 claims description 15
- 241000700605 Viruses Species 0.000 claims description 14
- 230000035772 mutation Effects 0.000 claims description 14
- 230000009261 transgenic effect Effects 0.000 claims description 14
- 108010031100 chloroplast transit peptides Proteins 0.000 claims description 13
- 230000002708 enhancing effect Effects 0.000 claims description 13
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims description 12
- 108090000051 Plastocyanin Proteins 0.000 claims description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 10
- 239000002299 complementary DNA Substances 0.000 claims description 10
- 108091026890 Coding region Proteins 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 9
- 241000233866 Fungi Species 0.000 claims description 8
- 241000238631 Hexapoda Species 0.000 claims description 8
- 230000001172 regenerating effect Effects 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 101150104463 GOS2 gene Proteins 0.000 claims description 7
- 244000020551 Helianthus annuus Species 0.000 claims description 7
- 230000000408 embryogenic effect Effects 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 6
- 240000005561 Musa balbisiana Species 0.000 claims description 6
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 6
- 241000244206 Nematoda Species 0.000 claims description 6
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 claims description 6
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 5
- 241000209510 Liliopsida Species 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 244000291564 Allium cepa Species 0.000 claims description 4
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 4
- 235000007319 Avena orientalis Nutrition 0.000 claims description 4
- 244000075850 Avena orientalis Species 0.000 claims description 4
- 240000002791 Brassica napus Species 0.000 claims description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 4
- 240000000111 Saccharum officinarum Species 0.000 claims description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 4
- 235000007238 Secale cereale Nutrition 0.000 claims description 4
- 244000082988 Secale cereale Species 0.000 claims description 4
- 240000003829 Sorghum propinquum Species 0.000 claims description 4
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 4
- 239000007975 buffered saline Substances 0.000 claims description 4
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 239000003053 toxin Substances 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 108700012359 toxins Proteins 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 3
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 3
- 240000000385 Brassica napus var. napus Species 0.000 claims description 3
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 3
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 3
- 229920000742 Cotton Polymers 0.000 claims description 3
- 108010070675 Glutathione transferase Proteins 0.000 claims description 3
- 102000005720 Glutathione transferase Human genes 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 244000299507 Gossypium hirsutum Species 0.000 claims description 3
- 235000021536 Sugar beet Nutrition 0.000 claims description 3
- 239000012620 biological material Substances 0.000 claims description 3
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims description 3
- 108020004999 messenger RNA Proteins 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 230000000392 somatic effect Effects 0.000 claims description 3
- 238000013518 transcription Methods 0.000 claims description 3
- 230000035897 transcription Effects 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 2
- 240000006108 Allium ampeloprasum Species 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 244000003416 Asparagus officinalis Species 0.000 claims description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 2
- 108700003918 Bacillus Thuringiensis insecticidal crystal Proteins 0.000 claims description 2
- 240000007124 Brassica oleracea Species 0.000 claims description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 2
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 101710132601 Capsid protein Proteins 0.000 claims description 2
- 108090000994 Catalytic RNA Proteins 0.000 claims description 2
- 102000053642 Catalytic RNA Human genes 0.000 claims description 2
- 108050004290 Cecropin Proteins 0.000 claims description 2
- 102000012286 Chitinases Human genes 0.000 claims description 2
- 108010022172 Chitinases Proteins 0.000 claims description 2
- 241000207199 Citrus Species 0.000 claims description 2
- 101710094648 Coat protein Proteins 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 108010002069 Defensins Proteins 0.000 claims description 2
- 102000000541 Defensins Human genes 0.000 claims description 2
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 2
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 2
- 101710123134 Ice-binding protein Proteins 0.000 claims description 2
- 101710082837 Ice-structuring protein Proteins 0.000 claims description 2
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 2
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- 108090001090 Lectins Proteins 0.000 claims description 2
- 102000004856 Lectins Human genes 0.000 claims description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 2
- 240000006240 Linum usitatissimum Species 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 101710125418 Major capsid protein Proteins 0.000 claims description 2
- 101710189714 Major cell-binding factor Proteins 0.000 claims description 2
- 235000011430 Malus pumila Nutrition 0.000 claims description 2
- 244000070406 Malus silvestris Species 0.000 claims description 2
- 235000015103 Malus silvestris Nutrition 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 240000004658 Medicago sativa Species 0.000 claims description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 2
- 244000061176 Nicotiana tabacum Species 0.000 claims description 2
- 101710141454 Nucleoprotein Proteins 0.000 claims description 2
- 206010034133 Pathogen resistance Diseases 0.000 claims description 2
- 241001148062 Photorhabdus Species 0.000 claims description 2
- 235000010582 Pisum sativum Nutrition 0.000 claims description 2
- 240000004713 Pisum sativum Species 0.000 claims description 2
- 241000209504 Poaceae Species 0.000 claims description 2
- 241000219000 Populus Species 0.000 claims description 2
- 101710083689 Probable capsid protein Proteins 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 235000014443 Pyrus communis Nutrition 0.000 claims description 2
- 240000001987 Pyrus communis Species 0.000 claims description 2
- 102100030000 Recombining binding protein suppressor of hairless Human genes 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims description 2
- 235000002096 Vicia faba var. equina Nutrition 0.000 claims description 2
- 108700002693 Viral Replicase Complex Proteins Proteins 0.000 claims description 2
- 108050006628 Viral movement proteins Proteins 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 2
- 238000009825 accumulation Methods 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 230000000692 anti-sense effect Effects 0.000 claims description 2
- 230000000840 anti-viral effect Effects 0.000 claims description 2
- 239000003899 bactericide agent Substances 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 230000001276 controlling effect Effects 0.000 claims description 2
- 101150102059 cry3Aa gene Proteins 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000005489 dwarf bean Nutrition 0.000 claims description 2
- 244000013123 dwarf bean Species 0.000 claims description 2
- 244000037666 field crops Species 0.000 claims description 2
- 239000004459 forage Substances 0.000 claims description 2
- 235000012055 fruits and vegetables Nutrition 0.000 claims description 2
- 230000000855 fungicidal effect Effects 0.000 claims description 2
- 239000000417 fungicide Substances 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 239000002917 insecticide Substances 0.000 claims description 2
- 239000002523 lectin Substances 0.000 claims description 2
- 239000005645 nematicide Substances 0.000 claims description 2
- 235000014571 nuts Nutrition 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 108091092562 ribozyme Proteins 0.000 claims description 2
- 108010076805 snowdrop lectin Proteins 0.000 claims description 2
- 230000009452 underexpressoin Effects 0.000 claims description 2
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims 1
- 102000006587 Glutathione peroxidase Human genes 0.000 claims 1
- 108700016172 Glutathione peroxidases Proteins 0.000 claims 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 229910010271 silicon carbide Inorganic materials 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 239000002609 medium Substances 0.000 description 128
- 210000004027 cell Anatomy 0.000 description 57
- 239000013612 plasmid Substances 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 229930006000 Sucrose Natural products 0.000 description 25
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 25
- 239000005720 sucrose Substances 0.000 description 25
- 239000012634 fragment Substances 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 24
- 230000008929 regeneration Effects 0.000 description 24
- 238000011069 regeneration method Methods 0.000 description 24
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 23
- 239000000725 suspension Substances 0.000 description 23
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 22
- 239000013615 primer Substances 0.000 description 21
- 108700019146 Transgenes Proteins 0.000 description 20
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 17
- 238000004114 suspension culture Methods 0.000 description 17
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 16
- 239000000872 buffer Substances 0.000 description 16
- 235000019157 thiamine Nutrition 0.000 description 16
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 16
- 229960003495 thiamine Drugs 0.000 description 16
- 239000011721 thiamine Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 229920001817 Agar Polymers 0.000 description 14
- 239000008272 agar Substances 0.000 description 14
- 239000000499 gel Substances 0.000 description 14
- 229960002429 proline Drugs 0.000 description 14
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 229940088594 vitamin Drugs 0.000 description 13
- 229930003231 vitamin Natural products 0.000 description 13
- 235000013343 vitamin Nutrition 0.000 description 13
- 239000011782 vitamin Substances 0.000 description 13
- 241000588724 Escherichia coli Species 0.000 description 12
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 12
- 229930182821 L-proline Natural products 0.000 description 12
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 229920002148 Gellan gum Polymers 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 230000012010 growth Effects 0.000 description 11
- 229960003512 nicotinic acid Drugs 0.000 description 11
- 235000001968 nicotinic acid Nutrition 0.000 description 11
- 239000011664 nicotinic acid Substances 0.000 description 11
- 210000001938 protoplast Anatomy 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 238000010367 cloning Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 235000008160 pyridoxine Nutrition 0.000 description 10
- 239000011677 pyridoxine Substances 0.000 description 10
- 229940011671 vitamin b6 Drugs 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- DTBNBXWJWCWCIK-UHFFFAOYSA-N Phosphoenolpyruvic acid Natural products OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 229960000367 inositol Drugs 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 9
- YQNRVGJCPCNMKT-LFVJCYFKSA-N 2-[(e)-[[2-(4-benzylpiperazin-1-ium-1-yl)acetyl]hydrazinylidene]methyl]-6-prop-2-enylphenolate Chemical compound [O-]C1=C(CC=C)C=CC=C1\C=N\NC(=O)C[NH+]1CCN(CC=2C=CC=CC=2)CC1 YQNRVGJCPCNMKT-LFVJCYFKSA-N 0.000 description 8
- 101100462537 Caenorhabditis elegans pac-1 gene Proteins 0.000 description 8
- 101100117764 Mus musculus Dusp2 gene Proteins 0.000 description 8
- 238000012217 deletion Methods 0.000 description 8
- 230000037430 deletion Effects 0.000 description 8
- 230000004927 fusion Effects 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 239000008223 sterile water Substances 0.000 description 8
- 238000001262 western blot Methods 0.000 description 8
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
- 239000005556 hormone Substances 0.000 description 7
- 229940088597 hormone Drugs 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 229960000268 spectinomycin Drugs 0.000 description 7
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 7
- 239000011550 stock solution Substances 0.000 description 7
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 240000007377 Petunia x hybrida Species 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 6
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 6
- 108010079058 casein hydrolysate Proteins 0.000 description 6
- 239000006285 cell suspension Substances 0.000 description 6
- 230000000977 initiatory effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 5
- 229930195725 Mannitol Natural products 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 239000012505 Superdex™ Substances 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 229960004261 cefotaxime Drugs 0.000 description 5
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 239000002577 cryoprotective agent Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 210000001161 mammalian embryo Anatomy 0.000 description 5
- 239000000594 mannitol Substances 0.000 description 5
- 235000010355 mannitol Nutrition 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- -1 triketone Chemical compound 0.000 description 5
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 5
- 229910052721 tungsten Inorganic materials 0.000 description 5
- 239000010937 tungsten Substances 0.000 description 5
- 238000003260 vortexing Methods 0.000 description 5
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 4
- 108020003589 5' Untranslated Regions Proteins 0.000 description 4
- QUTYKIXIUDQOLK-PRJMDXOYSA-N 5-O-(1-carboxyvinyl)-3-phosphoshikimic acid Chemical compound O[C@H]1[C@H](OC(=C)C(O)=O)CC(C(O)=O)=C[C@H]1OP(O)(O)=O QUTYKIXIUDQOLK-PRJMDXOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000005504 Dicamba Substances 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002105 Southern blotting Methods 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000005349 anion exchange Methods 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- IWEDIXLBFLAXBO-UHFFFAOYSA-N dicamba Chemical compound COC1=C(Cl)C=CC(Cl)=C1C(O)=O IWEDIXLBFLAXBO-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000012526 feed medium Substances 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000004161 plant tissue culture Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 4
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 4
- 229910001868 water Inorganic materials 0.000 description 4
- 229940023877 zeatin Drugs 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 101150021974 Adh1 gene Proteins 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 239000003155 DNA primer Substances 0.000 description 3
- 230000005526 G1 to G0 transition Effects 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 101001000581 Oryza sativa subsp. japonica Glucose-6-phosphate isomerase, cytosolic A Proteins 0.000 description 3
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000001166 ammonium sulphate Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 229960003669 carbenicillin Drugs 0.000 description 3
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000005138 cryopreservation Methods 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 238000001952 enzyme assay Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000000464 low-speed centrifugation Methods 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 230000010152 pollination Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 239000012882 rooting medium Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 3
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 2
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 2
- WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 description 2
- 108010000700 Acetolactate synthase Proteins 0.000 description 2
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 2
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 2
- 101100381930 Arabidopsis thaliana BPC3 gene Proteins 0.000 description 2
- 108010018763 Biotin carboxylase Proteins 0.000 description 2
- 238000009010 Bradford assay Methods 0.000 description 2
- 235000011293 Brassica napus Nutrition 0.000 description 2
- 108091027551 Cointegrate Proteins 0.000 description 2
- 241000287937 Colinus Species 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
- 101000931462 Homo sapiens Protein FosB Proteins 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 101710092857 Integrator complex subunit 1 Proteins 0.000 description 2
- 102100024061 Integrator complex subunit 1 Human genes 0.000 description 2
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 2
- 101100001026 Mus musculus Adh7 gene Proteins 0.000 description 2
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 2
- 229910019093 NaOCl Inorganic materials 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 101000893863 Oryza sativa subsp. japonica Glucose-6-phosphate isomerase, cytosolic B Proteins 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 102100020847 Protein FosB Human genes 0.000 description 2
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 description 2
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 229940122055 Serine protease inhibitor Drugs 0.000 description 2
- 101710102218 Serine protease inhibitor Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000034373 developmental growth involved in morphogenesis Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 210000004201 immune sera Anatomy 0.000 description 2
- 229940042743 immune sera Drugs 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000749 insecticidal effect Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 2
- 229960001669 kinetin Drugs 0.000 description 2
- 239000006194 liquid suspension Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 2
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 2
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 2
- 229910052939 potassium sulfate Inorganic materials 0.000 description 2
- 239000001120 potassium sulphate Substances 0.000 description 2
- 235000011151 potassium sulphates Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 239000003001 serine protease inhibitor Substances 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940063673 spermidine Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 239000013077 target material Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OJHZNMVJJKMFGX-RNWHKREASA-N (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;2,3-dihydroxybutanedioic acid Chemical compound OC(=O)C(O)C(O)C(O)=O.O=C([C@@H]1O2)CC[C@H]3[C@]4([H])N(C)CC[C@]13C1=C2C(OC)=CC=C1C4 OJHZNMVJJKMFGX-RNWHKREASA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- WNWOTMKHOLCHRJ-UHFFFAOYSA-N 1,4-dihydrotriazol-5-one Chemical compound O=C1CN=NN1 WNWOTMKHOLCHRJ-UHFFFAOYSA-N 0.000 description 1
- QMNWYGTWTXOQTP-UHFFFAOYSA-N 1h-triazin-6-one Chemical compound O=C1C=CN=NN1 QMNWYGTWTXOQTP-UHFFFAOYSA-N 0.000 description 1
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- NUPJIGQFXCQJBK-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid Chemical compound OC(=O)C1=CC(COC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 NUPJIGQFXCQJBK-UHFFFAOYSA-N 0.000 description 1
- MPPOHAUSNPTFAJ-UHFFFAOYSA-N 2-[4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC2=CC=C(Cl)C=C2O1 MPPOHAUSNPTFAJ-UHFFFAOYSA-N 0.000 description 1
- CABMTIJINOIHOD-UHFFFAOYSA-N 2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]quinoline-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O CABMTIJINOIHOD-UHFFFAOYSA-N 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- YHKBGVDUSSWOAB-UHFFFAOYSA-N 2-chloro-3-{2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-4-fluorophenyl}propanoic acid Chemical compound O=C1N(C(F)F)C(C)=NN1C1=CC(CC(Cl)C(O)=O)=C(Cl)C=C1F YHKBGVDUSSWOAB-UHFFFAOYSA-N 0.000 description 1
- ABOOPXYCKNFDNJ-UHFFFAOYSA-N 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 ABOOPXYCKNFDNJ-UHFFFAOYSA-N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- 238000004679 31P NMR spectroscopy Methods 0.000 description 1
- CTSLUCNDVMMDHG-UHFFFAOYSA-N 5-bromo-3-(butan-2-yl)-6-methylpyrimidine-2,4(1H,3H)-dione Chemical compound CCC(C)N1C(=O)NC(C)=C(Br)C1=O CTSLUCNDVMMDHG-UHFFFAOYSA-N 0.000 description 1
- 101150026777 ADH5 gene Proteins 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 229910001312 Amalgam (dentistry) Inorganic materials 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 238000006677 Appel reaction Methods 0.000 description 1
- 101100381932 Arabidopsis thaliana BPC5 gene Proteins 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- 108010000755 Bromoxynil nitrilase Proteins 0.000 description 1
- 101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 102000003849 Cytochrome P450 Human genes 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108700016256 Dihydropteroate synthases Proteins 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 239000005630 Diquat Substances 0.000 description 1
- 241001303048 Ditta Species 0.000 description 1
- 241001131785 Escherichia coli HB101 Species 0.000 description 1
- RXCPQSJAVKGONC-UHFFFAOYSA-N Flumetsulam Chemical compound N1=C2N=C(C)C=CN2N=C1S(=O)(=O)NC1=C(F)C=CC=C1F RXCPQSJAVKGONC-UHFFFAOYSA-N 0.000 description 1
- AOQMRUTZEYVDIL-UHFFFAOYSA-N Flupoxam Chemical compound C=1C=C(Cl)C(COCC(F)(F)C(F)(F)F)=CC=1N1N=C(C(=O)N)N=C1C1=CC=CC=C1 AOQMRUTZEYVDIL-UHFFFAOYSA-N 0.000 description 1
- 239000005535 Flurochloridone Substances 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 108030006517 Glyphosate oxidoreductases Proteins 0.000 description 1
- LXKOADMMGWXPJQ-UHFFFAOYSA-N Halosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2N(N=C(Cl)C=2C(O)=O)C)=N1 LXKOADMMGWXPJQ-UHFFFAOYSA-N 0.000 description 1
- 108010003774 Histidinol-phosphatase Proteins 0.000 description 1
- 101000740205 Homo sapiens Sal-like protein 1 Proteins 0.000 description 1
- 239000005566 Imazamox Substances 0.000 description 1
- 239000005981 Imazaquin Substances 0.000 description 1
- XVOKUMIPKHGGTN-UHFFFAOYSA-N Imazethapyr Chemical compound OC(=O)C1=CC(CC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 XVOKUMIPKHGGTN-UHFFFAOYSA-N 0.000 description 1
- 239000005570 Isoxaben Substances 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 239000005582 Metosulam Substances 0.000 description 1
- VGHPMIFEKOFHHQ-UHFFFAOYSA-N Metosulam Chemical compound N1=C2N=C(OC)C=C(OC)N2N=C1S(=O)(=O)NC1=C(Cl)C=CC(C)=C1Cl VGHPMIFEKOFHHQ-UHFFFAOYSA-N 0.000 description 1
- 239000005583 Metribuzin Substances 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 239000005586 Nicosulfuron Substances 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000005595 Picloram Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 239000012614 Q-Sepharose Substances 0.000 description 1
- 239000005616 Rimsulfuron Substances 0.000 description 1
- 102100037204 Sal-like protein 1 Human genes 0.000 description 1
- 108010070346 Salmine Proteins 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- CSPPKDPQLUUTND-NBVRZTHBSA-N Sethoxydim Chemical compound CCO\N=C(/CCC)C1=C(O)CC(CC(C)SCC)CC1=O CSPPKDPQLUUTND-NBVRZTHBSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 239000005618 Sulcotrione Substances 0.000 description 1
- 241000723792 Tobacco etch virus Species 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102100034593 Tripartite motif-containing protein 26 Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000006661 aam medium Substances 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960001413 acetanilide Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011157 advanced composite material Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 150000003931 anilides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- VGPYEHKOIGNJKV-UHFFFAOYSA-N asulam Chemical compound COC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VGPYEHKOIGNJKV-UHFFFAOYSA-N 0.000 description 1
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- OTSAMNSACVKIOJ-UHFFFAOYSA-N azane;carbamoyl(ethoxy)phosphinic acid Chemical compound [NH4+].CCOP([O-])(=O)C(N)=O OTSAMNSACVKIOJ-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- PPWBRCCBKOWDNB-UHFFFAOYSA-N bensulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)CC=2C(=CC=CC=2)C(O)=O)=N1 PPWBRCCBKOWDNB-UHFFFAOYSA-N 0.000 description 1
- ZOMSMJKLGFBRBS-UHFFFAOYSA-N bentazone Chemical compound C1=CC=C2NS(=O)(=O)N(C(C)C)C(=O)C2=C1 ZOMSMJKLGFBRBS-UHFFFAOYSA-N 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N chembl421 Chemical compound C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- RIUXZHMCCFLRBI-UHFFFAOYSA-N chlorimuron Chemical compound COC1=CC(Cl)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(O)=O)=N1 RIUXZHMCCFLRBI-UHFFFAOYSA-N 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 210000001726 chromosome structure Anatomy 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- OILAIQUEIWYQPH-UHFFFAOYSA-N cyclohexane-1,2-dione Chemical compound O=C1CCCCC1=O OILAIQUEIWYQPH-UHFFFAOYSA-N 0.000 description 1
- PAFZNILMFXTMIY-UHFFFAOYSA-O cyclohexylammonium Chemical compound [NH3+]C1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-O 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000032459 dedifferentiation Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000000448 dental amalgam Substances 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- SYJFEGQWDCRVNX-UHFFFAOYSA-N diquat Chemical compound C1=CC=[N+]2CC[N+]3=CC=CC=C3C2=C1 SYJFEGQWDCRVNX-UHFFFAOYSA-N 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 229960005437 etoperidone Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- OQZCSNDVOWYALR-UHFFFAOYSA-N flurochloridone Chemical compound FC(F)(F)C1=CC=CC(N2C(C(Cl)C(CCl)C2)=O)=C1 OQZCSNDVOWYALR-UHFFFAOYSA-N 0.000 description 1
- BGZZWXTVIYUUEY-UHFFFAOYSA-N fomesafen Chemical compound C1=C([N+]([O-])=O)C(C(=O)NS(=O)(=O)C)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 BGZZWXTVIYUUEY-UHFFFAOYSA-N 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006910 ice nucleation Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003617 indole-3-acetic acid Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- PMHURSZHKKJGBM-UHFFFAOYSA-N isoxaben Chemical compound O1N=C(C(C)(CC)CC)C=C1NC(=O)C1=C(OC)C=CC=C1OC PMHURSZHKKJGBM-UHFFFAOYSA-N 0.000 description 1
- OYIKARCXOQLFHF-UHFFFAOYSA-N isoxaflutole Chemical compound CS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1=C(C2CC2)ON=C1 OYIKARCXOQLFHF-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 229940099607 manganese chloride Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- FOXFZRUHNHCZPX-UHFFFAOYSA-N metribuzin Chemical compound CSC1=NN=C(C(C)(C)C)C(=O)N1N FOXFZRUHNHCZPX-UHFFFAOYSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- LZGUHMNOBNWABZ-UHFFFAOYSA-N n-nitro-n-phenylnitramide Chemical compound [O-][N+](=O)N([N+]([O-])=O)C1=CC=CC=C1 LZGUHMNOBNWABZ-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- RTCOGUMHFFWOJV-UHFFFAOYSA-N nicosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CN=2)C(=O)N(C)C)=N1 RTCOGUMHFFWOJV-UHFFFAOYSA-N 0.000 description 1
- NVGOPFQZYCNLDU-UHFFFAOYSA-N norflurazon Chemical compound O=C1C(Cl)=C(NC)C=NN1C1=CC=CC(C(F)(F)F)=C1 NVGOPFQZYCNLDU-UHFFFAOYSA-N 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WROZTZHKRRNHBS-UHFFFAOYSA-N phenyl propaneperoxoate Chemical compound CCC(=O)OOC1=CC=CC=C1 WROZTZHKRRNHBS-UHFFFAOYSA-N 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- NQQVFXUMIDALNH-UHFFFAOYSA-N picloram Chemical compound NC1=C(Cl)C(Cl)=NC(C(O)=O)=C1Cl NQQVFXUMIDALNH-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- LIOPHZNMBKHGAV-UHFFFAOYSA-M potassium;2-(phosphonomethylamino)acetate Chemical compound [K+].OC(=O)CNCP(O)([O-])=O LIOPHZNMBKHGAV-UHFFFAOYSA-M 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- MEFOUWRMVYJCQC-UHFFFAOYSA-N rimsulfuron Chemical compound CCS(=O)(=O)C1=CC=CN=C1S(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 MEFOUWRMVYJCQC-UHFFFAOYSA-N 0.000 description 1
- 230000021749 root development Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108020001482 shikimate kinase Proteins 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000030118 somatic embryogenesis Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- PQTBTIFWAXVEPB-UHFFFAOYSA-N sulcotrione Chemical compound ClC1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O PQTBTIFWAXVEPB-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 101150090317 tfdA gene Proteins 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Description
WG 0856756 PCT/GB00/01559
PI
HERBICIDE RESISTANT PLANTS
The present invention relates to recombinant DNA technology, and in particular to the production of transgenic plants which exhibit substantial resistance or substantial tolerance to herbicides when compared with non transgenic like plants. The invention also relates, inter alia, to the nucleotide sequences (and expression products thereof) which are used in the production of, or are produced by, the said transgenic plants.
Plants which are substantially “tolerant” to a herbicide when they are subjected to it provide a dose/response curve which is shifted to the right when compared with that provided by similarly subjected non tolerant like plants. Such dose/response curves have “dose” plotted on the x-axis and “percentage kill”, “herbicidal effect” etc. plotted on the y- axis. Tolerant plants will typically require at least twice as much herbicide as non tolerant like plants in order to produce a given herbicidal effect. Plants which are substantially “resistant” to the herbicide exhibit few, if any, necrotic, lytic, chlorotic or other lesions when
IS subjected to the herbicide at concentrations and rates which are typically employed by the agricultural community to kill weeds in the field in which crops are to be grown for commercial purposes.
It is particularly preferred that the plants are substantially resistant or substantially tolerant to herbicides (hereinafter "glyphosate") which have 5-enol pyruvyl shikimate phosphate synthetase (hereinafter "EPSPS") as their site of action, of which N- . phosphonomethylglycine (and its various salts) is the pre-eminent example.
The herbicide may be applied either pre- or post emergence in accordance with usual techniques for herbicide application to fields comprising crops which have been rendered resistant to the herbicide. The present invention provides, inter alia, nucleotide sequences useful in the production of such herbicide tolerant or resistant plants.
According to the present invention there is provided an isolated polynucleotide comprising the sequence depicted in SEQ ID No. 33. The invention also provides a polynucleotide, excluding the cDNA encoding the rice and corn EPSPS, which encodes an
EPSPS and which is complementary to one which when incubated at a temperature of between 65 and 70°C in 0.1 strength citrate buffered saline containing 0.1% SDS followed by rinsing at the same temperature with 0.1 strength citrate buffered saline containing 0.1%
SDS still hybridises with the sequence depicted in SEQ ID No. 33. An EPSPS encoding
¢ polynucleotide according to the invention may, however, be obtained by screening plant genomic DNA libraries with a nucleotide constituting an intron within the SEQ ID No. 33 sequence, and the invention also includes such a sequence obtainable from that screening.
The invention also includes an isolated polynucleotide comprising a region encoding a chloroplast transit peptide and a glyphosate resistant 5-enolpyruvylshikimate phosphate synthase (EPSPS) 3' of the peptide, the said region being under expression control of a plant operable promoter, with the provisos that the said promoter is not heterologous with respect to the said region, and the chloroplast transit peptide is not heterologous with respect to the said synthase.
By "heterologous" is meant from a different source, and correspondingly "non- heterologous” means derived from the same source - but at a gene rather than organism or tissue level. For example the CaMV 35S promoter is clearly heterologous with respect to a petunia EPSPS coding sequence insofar as the promoter is derived from a virus and the sequence - the expression of which it controls - from a plant. The term "heterologous" according to the present invention has a still narrower meaning, however. For example "heterologous" as it relates to the present invention means that the petunia EPSPS coding sequence is "heterologous" with respect to, for example, a promoter also derived from petunia - other than that which controls expression of the EPSPS gene. In this sense the petunia promoter derived from the petunia EPSPS gene then used to control expression of an
EPSPS coding sequence likewise-derived from petunia is "non-heterologous" with respect to the said coding sequence. "Non-heterologous"” does not mean, however, that the promoter . and coding sequence must necessarily have been obtained from one and the same (original or progenitor) polynucleotide. Likewise with respect to transit peptides. For example, a rubisco chloroplast transit peptide derived from sunflower is "heterologous" with respect to the coding sequence of an EPSPS gene likewise derived from sunflower (the same plant, tissue or cell). A rubisco transit peptide encoding sequence derived from sunflower is "non- heterologous" with respect to a rubisco enzyme encoding-sequence also derived from sunflower even if the origins of both sequences are different polynucleotides which may have been present in different cells, tissues or sunflower plants.
A preferred form of the polynucleotide comprises the following components in the 5' to 3' direction of transcription:-
‘WG 00766746 PCT/GB00/01559 or -3- : ~ : 1) At least one transcriptional enhancer being that enhancing region which is upstream from the transcriptional start of the sequence from which the enhancer is obtained and which enhancer per se does not function as a promoter either in the sequence in which it is endogenously comprised or when present heterologously as part of a construct; : (it) ~~ The promoter from the rice EPSPS gene; (111) ~~ The rice genomic sequence which encodes the rice EPSPS chloroplast transit peptide; (iv) The genomic sequence which encodes the rice EPSPS; (v) A transcriptional terminator; wherein the rice EPSPS coding sequence is modified in that a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which comprise the following conserved region
GNAGTAMRPLTAAV in the wild type enzyme such that modified sequence reads
GNAGIAMRSLTAAV.
The enhancing region preferably comprises a sequence the 3’ end of which is at least 40 nucleotides upstream of the closest transcriptional start of the sequence from which the \ enhancer is obtained. In a further embodiment of the polynucleotide, the enhancing region comprises a region the 3” end of which is at least 60 nucleotides upstream of the said closest . start, and in a still further embodiment of the polynucleotide the said enhancing region comprises a sequence the 3’ end of which is at least 10 nucleotides upstream from the first nucleotide of the TATA consensus of the sequence from which the enhancer is obtained.
The polynucleotide according to the invention may comprise two or more transcriptional enhancers, which in a particular embodiment of the polynucleotide may be tandemly present.
In the present inventive polynucleotide the 3’ end of the enhancer, or first enhancer if there is more than one present, may be between about 100 to about 1000 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide or the first nucleotide of an intron in the 5' untranslated region in the case that the said region contains an intron. In a more preferred embodiment of the polynucleotide, the 3’ end of the enhancer, or first enhancer, is between about 150 to about 1000 nucleotides upstream of the
: ‘0. codon corresponding to the translational start of the EPSPS transit peptide or the first nucleotide of an intron in the 5' untranslated region, and in a still more preferred embodiment the 3’ end of the enhancer, or first enhancer, may be between about 300 to about 950 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide or the first nucleotide of an intron in the 5' untranslated region. In a yet more preferred embodiment, the 3” end of the enhancer, or first enhancer, may be located between about 770 and about 790 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide or the first nucleotide of an intron in the 5' untranslated region.
In an alternative inventive polynucleotide, the 3’ end of the enhancer, or first enhancer, may be located between about 300 to about 380 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide or the first nucleotide of an intron in the 5' untranslated region, and in a preferred embodiment of this alternative polynucleotide the 3’ end of the enhancer, or first enhancer, is located between about 320 to about 350 nucleotides upstream of the codon corresponding to the translational start of the
EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
In the polynucleotide according to the invention, the region upstream of the promoter from the rice EPSPS gene may comprise at least one enhancer derived from a sequence which is upstream from the transcriptional start of either the barley plastocyanin or GOS2 ‘ promoters.
Accordingly the polynucleotide may comprise in the 5' to 3' direction a first enhancer : comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of either the barley plastocyanin promoter and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the GOS 2 promoter. : Alternatively, the polynucleotide may comprise in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the GOS 2 promoter and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the barley plastocyanin promoter.
Whatever the identity and juxtaposition of the various enhancers present in the polynucleotide, the nucleotides 5' of the codon which constitutes the translational start of the
‘WG 00/66746 PCT/GB00/01559
Je -5- rice EPSPS chloroplast transit peptide may be Kozack preferred. The skilled man will know what is meant by this - which in any case is further apparent from the following examples.
Particularly preferred embodiments of the present inventive polynucleotide have a non-translated region which comprises a sequence which functions as an intron located 5' of the rice genomic sequence which encodes the rice EPSPS chloroplast transit peptide. The non-translated region may comprise the sequence depicted in SEQ ID NO. 40. In particular, the non-translated region may comprise the maize ADHI intron and have the sequence in
SEQ ID NO. 40.
The polynucleotide of the invention may comprise a virally derived translational enhancer located within the non translated region 5' of the rice genomic sequence which encodes the rice EPSPS chloroplast transit peptide. The man skilled in the art is aware of the identity of such suitable translational enhancers - such as the Omega and Omega prime sequences derived from TMV and that derived from the tobacco etch virus, and how such translational enhancers can be introduced into the polynucleotide so as to provide for the desired result.
The polynucleotide according to the invention may further comprise regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, , stress, dessication, and herbicides. Whilst such a polynucleotide contemplates the herbicide resistance conferring gene being other than an EPSPS, such as glyphosate oxido-reductase . (GOX) for example, the herbicide may be other than glyphosate in which case the resistance conferring genes may be selected from the group encoding the following proteins: phosphinothricin acetyl transferase (PAT), hydroxypheny! pyruvate dioxygenase (HPPD), glutathione S transferase (GST), cytochrome P450, Acetyl-COA carboxylase (ACCase), Acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), dihydropteroate synthase, polyamine transport proteins, superoxide dismutase (SOD), bromoxynil nitrilase, phytoene desaturase (PDS), the product of the tfdA gene obtainable from Alcaligenes eutrophus, and known mutagenised or otherwise modified variants of the said proteins. In the case that the polynucleotide provides for multiple herbicide resistance such herbicides may be selected from the group consisting of a dinitroaniline herbicide, triazolo-pyrimidines, uracil, a phenylurea, triketone, isoxazole, acetanilide, oxadiazole, triazinone, sulfonanilide, amide, anilide, RP201772, flurochloridone, norflurazon, and triazolinone type herbicide apd the post-
emergence herbicide is selected from the group consisting of glyphosate and salts thereof, glufosinate, asulam, bentazon, bialaphos, bromacil, sethoxydim or another cyclohexanedione, dicamba, fosamine, flupoxam, phenoxy propionate, quizalofop or another aryloxy- phenoxypropanoate, picloram, fluormetron, atrazine or another triazine, metribuzin, chlorimuron, chlorsulfuron, flumetsulam, halosulfuron, sulfometron, imazaquin, imazethapyr, isoxaben, imazamox, metosulam, pyrithrobac, rimsulfuron, bensulfuron, nicosulfuron, fomesafen, fluroglycofen, KIH9201, ET751, carfentrazone, ZA1296, sulcotrione, paraquat, diquat, bromoxynil and fenoxaprop.
In the case that the polynucleotide comprises sequences encoding insecticidal ~ 10 proteins, these proteins may be selected from the group consisting of crystal toxins derived from Bt, including secreted Bt toxins; protease inhibitors, lectins,
Xenhorabdus/Photorhabdus toxins; the fungus resistance conferring genes may be selected from the group consisting of those encoding known AFPs, defensins, chitinases, glucanases,
Avr-Cf9. Particularly preferred insecticidal proteins are crylAc, crylAb, cry3A, Vip 1A, Vip 1B, cystein protease inhibitors, and snowdrop lectin. In the case that the polynucleotide comprises bacterial resistance conferring genes these may be selected from the group consisting of those encoding cecropins and techyplesin and analogues thereof. Virus resistance conferring genes may be selected from the group consisting of those encoding virus coat proteins, movement proteins, viral replicases, and anti-sense and ribozyme . sequences which are known to provide for virus resistance; whereas the stress, salt, and drought resistance conferring genes may be selected from those that encode Glutathione-S- . transferase and peroxidase, the sequence which constitutes the known CBF1 regulatory sequence and genes which are known to provide for accumulation of trehalose.
The polynucleotide according to the invention may be modified to enhance expression of the protein encoding sequences comprised by it, in that mRNA instability motifs and/or fortuitous splice regions may be removed, or crop preferred codons may be used so that expression of the thus modified polynucleotide in a plant vields substantially similar protein having a substantially similar activity/function to that obtained by expression } of the unmodified polynucleotide in the organism in which the protein encoding regions of the unmodified polynucleotide are endogenous. The degree of identity between the modified polynucleotide and a polynucleotide endogenously contained within the said plant and encoding substantially the same protein may be such as to prevent co-suppression between
7 -7- the modified and endogenous sequences. In this case the degree of identity between the sequences should preferably be less than about 70%.
The invention still further includes a biological or transformation vector comprising the present inventive polynucleotide. Accordingly, by "vector" is meant, inter alia, one of the following: a plasmid, virus, cosmid or a bacterium transformed or transfected so as to contain the polynucleotide.
The invention still further includes plant material which has been transformed with the said polynucleotide or vector, as well as such transformed plant material which has been, or is, further transformed with a polynucleotide comprising regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, dessication, and herbicides.
The invention still further includes morphologically normal, fertile whole plants which have been regenerated from the material disclosed in the immediately preceding
IS paragraph, their progeny seeds and parts, which progeny comprises the polynucleotide or vector of the invention stably incorporated into its genome and heritable in a Mendelian manner.
The invention still further includes morphologically normal fertile whole plants , which contain the present inventive polynucleotide and which result from the crossing of plants which have been regenerated from material transformed with the present inventive ] polynucleotide or vector, and plants which have been transformed with a polynucleotide comprising regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, dessication, and herbicides, the progeny of the resultant plants, their seeds and parts.
Plants of the invention may be selected from the group consisting of field crops, fruits and vegetables such as canola, sunflower, tobacco, sugar beet, cotton, maize, wheat, barley, rice, sorghum, tomato, mango, peach, apple, pear, strawberry, banana, melon, potato, carrot, lettuce, cabbage, onion, soya spp, sugar cane, pea, field beans, poplar, grape, citrus, alfalfa, rye, oats, turf and forage grasses, flax and oilseed rape, and nut producing plants insofar as they are not already specifically mentioned, their progeny, seeds and parts.
Particularly preferred such plants include maize, soybean, cotton, sugar beet and canola.
The invention still further comprises a method of selectively controlling weeds in a field, the field comprising weeds and plants of the invention or the herbicide resistant progeny thereof, the method comprising application to the field of a glyphosate type. herbicide in an amount sufficient to control the weeds without substantially affecting the plants. According to this method, one or more of a herbicide, insecticide, fungicide, nematicide, bacteriocide and an anti-viral may be applied to the field (and thus the plants contained within it) either before or after application of the glyphosate herbicide.
The invention still further provides a method of producing plants which are substantially tolerant or substantially resistant to glyphosate herbicide, comprising the steps of: (1) transforming plant material with the polynucleotide or vector of the invention: (i1) selecting the thus transformed material; and (iii) regenerating the thus selected material into morphologically normal fertile whole plants.
The transformation may involve the introduction of the polynucleotide into the material by any known means, but in particular by: (i) biolistic bombardment of the material with particles coated with the polynucleotide; (ii) by impalement of the material on silicon . carbide fibres which are coated with a solution comprising the polynucleotide; or (iii) by introduction of the polynucleotide or vector into Agrobacterium and co-cultivation of the LL - thus transformed Agrobacterium with plant material which is thereby transformed and is subsequently regenerated. Plant transformation, selection and regeneration techniques, which may require routine modification in respect of a particular plant species, are well known to the skilled man. The thus transformed plant material may be selected by its resistance to glyphosate.
The invention still further provides the use of the present inventive polynucleotide or vector in the production of plant tissues and/or morphologically normal fertile whole plants which are substantially tolerant or substantially resistant to glyphosate herbicide.
The invention still further includes a method of selecting biological material transformed so as to express a gene of interest, wherein the transformed material comprises the polynucleotide or vector of the invention, and wherein the selection comprises exposing
“WG 00/66736 PCT/GBO0/01559 the transformed material to glyphosate or a salt thereof, and selecting surviving material.
The said material may be of plant origin, and may in particular be derived from a monocot selected from the group consisting of barley, wheat, corn, rice, oats, rye, sorghum, pineapple, sugar cane, banana, onion, asparagus and leek.
The invention still further includes a method for regenerating a fertile transformed plant to contain foreign DNA comprising the steps of: (a) producing regenerable tissue from said plant to be transformed; (b) transforming said regenerable tissue with said foreign DNA, wherein said foreign DNA comprises a selectable DNA sequence, wherein said sequence functions in a regenerable tissue as a selection device; (c) between about one day to about 60 days after step (b), placing said regenerable tissue from step (b) in a medium capable of producing shoots from said tissue, wherein said medium further contains a compound used to select regenerable tissue containing said selectable DNA sequence to allow identification or selection of the transformed regenerated tissue; (d) after at least one shoot has formed from the selected tissue of step (c) transferring said shoot to a second medium capable of producing roots from said shoot to produce a plantlet, wherein the second medium optionally contains the said } compound; and (e) growing said plantlet into a fertile transgenic plant wherein the foreign DNA ] is transmitted to progeny plants in Mendelian fashion, characterised in that the foreign DNA is, or the selectable DNA sequence comprised by the foreign DNA comprises, the polynucleotide according to any one of claims 1 to 34, and the said compound is glyphosate or a salt thereof. The plant may be a monocot as indicated above - more preferably selected from banana, wheat, rice, corn and barley and the said regenerable tissue may consist of embryogenic calli, somatic embryos, immature embryos etc.
The present invention will be further apparent from the following description taken in conjunction with the associated drawings and sequence listings.
List of Sequences
SEQID NO. 1-32 PCR primers.
SEQ ID NO. 33 Rice genomic EPSPS sequence (from ATG).
SEQ ID NO. 34 Rice genomic EPSPS sequence containing double mutation.
SEQ ID NO. 35 GOS2 enhancer.
SEQ ID NO. 36 BPC enhancer.
SEQ ID NO. 37 Rice Genomic G1 EPSPS (to ATG) - SEQ ID NO. 38 Rice Genomic G3 EPSPS (to ATG). : 5 SEQID NO. 39 Rice Genomic G2 EPSPS +Maize Adhl intron
SEQ ID NO. 40 Maize Adhl intron
List of Figures - Figure 1 Rice EPSPS genomic schematic map.
Figure 2 Vector pCR4-OSEPSPS (rice dmEPSPS gene in vector pCR4-Blunt)
Figure 3 Schematic representation of strategy used to introduce the double mutation.
Figure 4 Vector pTCV1001
Figure 5 Vector pTCV10010SEPSPS (comprising rice dmEPSPS gene in vector pTCV1001). : Figure 6 Vector pTCV1001EPSPSPAC (comprising rice dmEPSPS gene in vector pTCV1001).
Figure 7 Vector pBluSK+EPSPS (comprising rice dmEPSPS gene in vector pBluescript
SK+).
Figure 8 Vector pPAC1
Figure 9 Vector p TCVEPSPSPH .
Figure 10 Vector p TCVEPSPSADH
Figure 11 Vector pBluSKEPSPSADH (comprising rice dmEPSPS gene containing Adhl . intron)
Figure 12 Vector pIGPD9
Figure 13 Vector Zen 8
Figure 14 Vector Zen 19
Figure 15 Vector Zen 21
Figure 16 Introduction of Zen vectors into superbinary vectors
Production of plants tolerant to glyphosate treatment through over-expression of a mutated EPSPS under the control of a non-heterologous promoter.
The term ‘enhancer’ as used throughout this specification refers to sequences upstream of a promoter which do not comprise the promoter itself but which act to enhance and regulate transcription from the promoter
The term “EPSPS promoter deletion” as used throughout this specification refers to the EPSPS promoter together with various nucleotides of the transcriptional enhancer of the
EPSPS, which nucleotides are upstream (5) of the promoter.
In respect of the transformation of plant material, those skilled in the art will recognise that although particular types of target material (e.g. embryogenic cell suspension culture or dedifferentiating immature embryos) and particular methods of transformation (e.g. using Agrobacterium or particle bombardment) are specified in the examples below, the present invention is not limited to these particular embodiments and such target materials and methods may be used interchangeably. Furthermore, the term “plant cells” as used throughout this description of the invention can refer to isolated cells, including suspension cultures as well as to cells in an intact or partly intact tissue such as embryo, scutella, microspore, microspore-derived embryo or somatic cells from plant organs. Similarly, although the specific examples are limited to maize, wheat and rice, the invention is equally applicable © any of a broad range of agricultural crops and amenity plants which can be transformed using suitable methods of plant cell transformation.
General molecular biological methods are carried out according to Sambrook er al (1989) * Molecular cloning: A laboratory Manual, 2 nd Edn. Cold Spring Harbour Lab. Press.
EXAMPLE 1. Generation of a cDNA probe for Rice EPSPS : . A partial length cDNA encoding rice EPSPS is obtained using reverse transcriptase
PCR (RT-PCR). Total RNA is isolated from two-week-old rice plants (Oryza sativa L.indica . var. Koshihikari) using the TRI-ZOL™ method (Life Technologies). First-strand cDNA synthesis is performed using Superscript II reverse transcriptase (Life Technologies) with 200 ng of EPSPS degenerate reverse 10 primer (SEQ ID NO.1) and 2 pg of total RNA according to the supplied protocols. Second strand synthesis and cDNA amplification by PCR is performed using EPSPS degenerate primers 10 and 4 (SEQ ID NO.1 and SEQ ID NO.2) and
PCR beads (Pharmacia) according to the manufacturers instructions. All letter codes are standard abbreviations (Eur. J. Biochem. (1985) 150:15)
SEQ ID NO.1
EPSPS degenerate reverse 10 5’ GCACARGCIGCAAGIGARAAIGCCATIGCCAT 3’
SEQIDNO.2
EPSPS degenerate forward 4 5’ GCWGGAACWGCMATGCGICCRYTIACIGC 3°
The products are cloned into vector pCR2.1 (Invitrogen) using a TA Cloning kit™ as recommended by the supplier. Plasmid is recovered from selected colonies and the sequence analysed by a process involving computer based homology searches (BLAST) to confirm that = the cloned RT-PCR product shows high homology to known plant EPSPS sequences. - 5 EXAMPLE 2. Isolation of Rice EPSPS genomic sequence and cloning of the rice : EPSPS gene
A region of genomic DNA containing the full rice EPSPS gene and 5° upstream region is isolated from a A EMBLSP6/T7 genomic library constructed from five-day-old etiolated rice shoots (Oryza sativa L.Indica var. IR36) (Clontech). 1x10° plaque forming units (pfu) are screened using the 32p_labelled rice EPSPS cDNA probe (example 1) using protocols provided by the manufacturer. Positive plaques are subjected to subsequent rounds of hybridisation screening until plaque purity of a cross-hybridising plaque is obtained. A-
DNA is prepared from the phage pure stock, according to the method described by Sambrook et al., 1989. The DNA obtained is analysed by restriction digest and Southern blotting, using the same **P-labelled rice EPSPS cDNA as a probe. Restriction fragments that cross- hybridise are, where applicable, blunt-ended using a method such as Perfectly Blunt™ (Novagen), and cloned into a suitable vector such as pSTBlue (Novagen). The DNA is then sequenced using an ABI 377A PRISM automated DNA sequencer. Figure 1 shows a schematic of the rice EPSPS gene with some of the restriction sites marked. :
A 3.86 kb fragment of the rice EPSPS gene, containing the coding region, the EPSPS promoter, some of the 5’ upstream region and the terminator is obtained by PCR. :
Oligonucleotide primer OSGRA1 (SEQ ID NO.3) is used in conjunction with OSEPSPS3 (SEQ ID NO. 4) to amplify the desired region. OSEPSPS3 contains additional Sac 1 and Sma 1 restriction enzyme sites to facilitate the subcloning of the gene during the later stages of vector construction. A schematic location of these primers is given in Figure 1.
SEQ ID NO. 3
OSSGRAL 5° ATT TCT TCT TCT TCC TCC CTT CIC CgC CTC 3'
SEQID NO. 4 .
OSEPSPS3 s' gag crc ccc ggg CoA gTg TTg TTg TgT TCT gTC TAA Tg 3° :
High fidelity Pfu Turbo™ polymerase (Stratagene) is used to perform the PCR reaction with DNA obtained from A preparation (described above) as the amplification template. The PCR product of expected size is cloned into pCRblunt 4-TOPO™ (Invitrogen) and sequenced to check integrity.
EXAMPLE 3. Mutation of T to I and P to S in the rice EPSPS.
The T to I and P to S mutation is obtained by. the introduction of two point mutations.
These mutations are introduced into the rice genomic EPSPS gene by PCR using oligonucleotide primers containing the desired mutation. A schematic diagram, indicating the binding sites of the primers used, is shown in Figure 3. Two separate PCR reactions are performed (both using the A DNA as template). 1) EcoRVEnd (SEQ ID NO.5) + OSMutBot (SEQ ID NO. 6) 2) OsMutTop (SEQ ID NO. 7) + SallEnd (SEQ ID NO. 8)
SEQ ID NO.5
EcoRVEnd 5’ GCTTACGAAGGTATGATATCCTCCTACATGTCAGGC 3°
SEQ ID NO.6
OSMutBot 5’ GCAGTCACGGCTGCTGTCAATGATCGCATTGCAATTCCAGCGTTCC 3° SEQID NO.7
OsMutTop 5’ GGAACGCTGGAATTGCAATGCGATCATTGACAGCAGCCGTGACTGC 3’
SEQ ID NO.8
SallEnd 5‘ GGTGGGCATTCAGTGCCAAGGAAACAGTCGACATCCGCACCAAGTTGTTTCAACC 3
The resulting PCR products are joined by using equimolar concentrations of each
PCR product as template with the two oligos SallEnd and EcoRVEnd in a new PCR reaction.
An aliquot of the reaction product is analysed by agarose gel electrophoresis and cloned into pCR-Blunt II™ (Invitrogen). Plasmid DNA is recovered and sequenced to detect the successful incorporation of the double mutation.
The DNA fragment containing the double mutation is incorporated into the rice
EPSPS genomic clone (Figure 1) as follows. The clone containing the double mutant is digested with Eco RV and Sai I. The plasmid containing the rice EPSPS DNA PCR product is similarly digested and the Eco RV/Sal I fragment containing the double mutant ligated into the rice EPSPS gene in pCR4Blunt -TOPO™ using standard cloning methods described in
Sambrook er al., 1989 and transformed into competent E. coli. Plasmid is recovered from resultant colonies and sequenced in order to confirm the presence of the double mutation with no further alterations. This plasmid, pCR4-OSEPSPS, is shown in figure 2.
The genomic rice EPSPS gene containing the double mutant (Figure 2) is excised from pCR4-Blunt-TOPO™ using Pst 1 and Not 1 and ligated into vector pTCV1001 (Figure 4), to generate pTCV10010SEPSPS (figure 5) and this is transformed into E. coli for amplification. Next, the Pac 1/Eco RV restriction fragment is excised from the A DNA (figure 1) and inserted into pTCV10010SEPSPS (figure 5) to generate pTCVI001EPSPSPAC (figure 6). The rice dmEPSPS gene, now containing sequence from
Pac 1 to Sacl (Figure 6), is excised from pTCV1001EPSPSPAC (figure 6) as an Eag 1/Sac 1 fragment and ligated into similarly digested pBluescript SK+ to make pBluSK+EPSPS (Figure 7). Further rice EPSPS upstream regions and desired enhancers are assembled (as described below) and ligated into the pBluescript SK+ vector using Xba 1/Pac 1.
EXAMPLE 4. Generation of singly enhanced : rice EPSPS promoter fusions
Figure 1 indicates the binding sites of the primers G1 and G2 used to generate a series of deletions at the 5' end of the rice EPSPS gene. The G1 and G2 primers (SEQ ID NO 9 and
SEQ ID NO 10) are used in combination with the RQCR10 primer (SEQ ID NO 11) using the rice EPSPS lambda DNA template and Pfu Turbo™ polymerase (Stratagene) using protocols provided by the supplier.
SEQ ID NO.9
Gl 5’ CGCCTGCAGCTCGAGGTTGGTTGGTGAGAGTGAGACACC 3°
SEQ ID NO.10 :
G2 5’ CGCCTGCAGCTCGAGGCCACACCAATCCAGCTGGTGTGG 3’
SEQ ID NO.11 :
RQCRI10 5’ GAACCTCAGTTATATCTCATCG 3°
The products obtained are analysed by agarose gel electrophoresis and cloned into
PCR-Blunt II-TOPO™ vector (Invitrogen). The sequence of the resulting products is determined to ensure that there is no alteration in the sequence of the rice genomic EPSPS clone. Clones to progress are selected based on their orientation within the vector by establishing whether or not Xho I digestion removes only the polylinker sequence rather than the whole insert from the vector.
The sequences of the barley plastocyanin and rice GOS2 genes and their associated 5° upstream regions are published in the EMBL database (Z28347 and X51910). Primers are designed so as to amplify only the upstream enhancer regions of the said genes. The barley plastocyanin enhancer (SEQ ID NO. 36) is thus obtained by PCR using primers SEQ ID NO.
g -15- 12 and SEQ ID NO. 13 in conjunction with Pfu Turbo™ polymerase and barley genomic
DNA as the template. The GOS2 enhancer (SEQ ID NO 35) is obtained in a similar manner using primers (SEQ ID No 14 and SEQ ID No 15) with rice genomic DNA as template.
The following oligonucleotide primers are used.
SEQIDNO. 12
BPC5 5’ CGCTCTAGAGGCCGGCCCCAAAATCTCCCATGAGGAGCACC 3°
SEQ ID NO. 13
BPC3 5’ CGCTGCAGCTCGAGCCGCCTCTCCATCCGGATGAGG 3°
SEQID NO. 14
GOSs 5’ CGCTCTAGAGGCCGGCCGAATCCGAAAAGTTTCTGCACCGTTTTCACC 3°
SEQID NO. 15
GOS3 5' CGCTGCAGCTCGAGGCTGTCCTCCGTTAGATCATCG 3
The sequence of the amplified and cloned molecules is confirmed following cloning into the PCR Blunt-II-TOPO vector (Invitrogen). The pCR Blunt-II-TOPO vector, containing the EPSPS 5’UTR deletion is digested with Xba 1/Xho 1. The Enhancer is removed from its respective pCR Blunt-II-TOPO vector also using Xba 1/Xho 1 digestion and ligated into the first vectors containing the EPSPS promoter deletions generated by PCR.
EXAMPLE S. Generation of doubly enhanced : rice EPSPS promoter fusions. . In order to further increase expression from the rice EPSPS promoter a second enhancer, comprising either the barley plastocyanin or rice GOS?2 is introduced. In one ] example of a cloning strategy to achieve this end, enhancer/EPSPS fusions are initially made (as described in example 4) comprising a single (first) enhancer. The second enhancer, also being either that from barley plastocyanin or rice GOS2 is amplified using the primers
BPCXho and BPC3 (SEQ ID NO 16 and SEQ ID NO 13) or GOS2Xho and GOS3 (SEQ ID
NO 17 and SEQ ID NO 15) respectively. These primers facilitate the introduction of a Xhol site at the 5’ and 3’ termini of the enhancer.
SEQ ID NO.16
BPCXho 5‘ ctcgagGGCCGGCCgcagetggetty 3°
SEQ ID NO. 17
GOS2XHO 5’ ctcgagttttgtggtcgtcactgegtteg 3°
-16- ¢
Once sequenced, the PCR product (as Xho 1 : Xho 1) is introduced into the construct which comprises the first enhancer : EPSPS gene fusion either at the Xhol site. The orientation of the enhancer is determined by PCR.
EXAMPLE 6. Insertion of Adh1 intron into the 5’ UTR of the rice EPSPS gene
The insertion of the Maize Adhl intron 1 into the desired rice EPSPS promoter deletion (e.g. made as described in Example 4) is performed prior to the generation of the fusion construct with the desired enhancer(s). In this particular example the Adhl intron is introduced into the G2 EPSPS promoter deletion. The skilled man will appreciate that similar methodology can be adopted to incorporate the Adhl intron into other EPSPS promoter deletions. The maize Adhl intron is inserted into the constructs by PCR. The Adh 1 intron is amplified from a suitable source, such as maize genomic DNA or a vector such as pPAC1 (Figure 8) using primers AdhS5 (SEQ ID NO. 18) and Adh3 (SEQ ID NO. 19):
SEQIDNO. 18
Adh5 cccatectcecgacctecacgeecgeeggeaggat caagtgcaaaggt cogocttgtttetectety
SEQID NO. 19
Adh3 gacgccatggtegecgeeatcegeagetgeacgggtccaggaaageaate
The resulting PCR product is denatured and used as a primer in conjunction with
Adh5Pac (SEQ ID NO. 20) to amplify the desired product using the vector pTCV1001EPSPSPAC (Figure 2) as template. .
SEQID NO. 20
Adh5Pac cgagttettatagtagatttcaccttaattaaaac .
The resulting PCR product is cloned into PCR-blunt II (Invitrogen). The Pac 1:Hind
III fragment is excised from the rice genomic clone (Figure 1) and inserted into pTCV1001 to generate pTCVEPSPSPH (Figure 9). Next, the Pac I/Nco 1 PCR product comprising the Adhl intron is inserted into pTCVEPSPSPH as shown in the schematic (Figure 9). The Pac 1:Eco RV fragment present in the cloned EPSPS gene containing the double mutant (Figure 10) is excised and replaced with the Pac 1/Eco RV fragment from pTCVEPSPSPH that comprises the Adhl intron sequences (Figure 9). Finally the full EPSPS gene comprising the
Adh 1 sequence is excised from pTCVEPSPSPH as an Eag 1/Sac 1 fragment and cloned into pBluescript SK+to give pBluSKEPSPSADH (figure 11).
"WG 00/66716 PCT/GB00/01559
EXAMPLE 7. Introduction of optimised pre ATG consensus sequence (Kozak) via site directed mutagenesis for constructs comprising the maize adhl intron.
Optionally, site directed mutagenesis is performed on constructs containing the Adhl intron using the QuickChange Site Directed Mutagenesis Kit (Stratagene). This is performed onthe Pacl/Sacl EPSPS fragment in pBluescript SK+ (Figure 11) prior to fusion with the enhancer : EPSPS promoter fusions. The following oligonucleotide are used according to the supplied protocols to optimise the KOZAK sequence.
SEQ ID NO. 21
Oskozak 5’ GGACCCGTGCAGCTGCGGTACCATGGCGGCGACCATGGC 3°
SEQIDNO. 22
OSkozakrev 5’GCCATGGTCGCCGCCATGGTACCGCAGCTGCACGGGTCC 3°
Clones are analysed by restriction analysis, using Kpn 1, on recovered plasmid. The correctly altered DNA is characterised by an additional Kpn 1 restriction site compared to the un- altered DNA. The sequence is then verified by automated DNA sequencing.
The altered DNA sequence may be transferred original constructs using the unique restriction enzyme sites of Sph 1 or Pac 1 atthe 5’ end and Avr Il or Eco RV at the 3’ end as appropriate : for each vector.
EXAMPLE 8. Completion of EPSPS expression cassettes comprising, in the 5’ to 3’ ] direction, Enhancer region(s), rice EPSPS promoter upstream region, EPSPS promoter, EPSPS 5’UTR + (optional) maize Adh1 intron 1, rice EPSPS plastid transit } peptide coding region, rice mature EPSPS coding region and rice EPSPS gene terminator region .
The singly and doubly enhanced rice EPSPS promoter fusions (Examples 4 and 5) contained within the pCR Blunt-II-TOPO vectors are excised using Xba 1 and Pac 1 and inserted into the similarly digested pBluescript SK+ clone containing the remainder of the rice EPSPS sequence (Figures 7/11). This final cloning step results in the required gene constructs. Examples of EPSPS expression cassettes obtainable using the above strategies are given below in Table 1. Schematic maps are given in Figures 13-15.
-18- y “Clone First Second EPSPS Promoter Adnhl EPSPS EPSPS enhancer enhancer deletion Intron genomic coding Terminator region "ZENT GOS None GI No Ye Ye
ZENS BPC None © GI No Yes Yes
ZEN17 GOS None G2 Yes Yes Yes
ZENI9 BPC None G2 Yes Yes Yes
ZEN21 BPC GOS G2 Yes Yes Yes
ZEN?22 GOS BPC G2 Yes Yes Yes -_—
EXAMPLE 9. Subcloning of EPSPS expression cassettes from pBluescript SK+ into plGPD9
Where desired and especially for transformation of plants by direct DNA methods (whiskers, bombardment and protoplasts), the EPSPS expression constructs are excised from pBluescript using Xma 1 and cloned into pIGPD9 (Figure 12). The use of this vector for transformation avoids transfer of antibiotic resistance genes to the plant since selection relies on complementation of an E.coli histidine auxotroph with the gene encoding IGPD. The pIGPD9-derived plasmids deriving from insertion of the Xma 1 fragments of pZEN 7, 8, 17, 19, 21 and 22 are termed ZEN7i, pZENSi, pZEN17i, pZEN19i, pZEN21i and pZEN22i.
Large DNA preparations for use in plant transformation are obtained using the Maxi- prep procedure (Qiagen) using protocols provided by the Manufacturer
EXAMPLE 10. Preparation of DNA for plant transformation
The above procedure describes the assembly of ‘EPSPS expression cassettes’ comprising, in a 5° to 3’ direction, an enhancer sequence(s), an EPSPS promoter from rice, a region encoding a rice EPSPS transit peptide, a region encoding a mature rice EPSPS enzyme which is resistant to glyphosate through having T to I and P to S changes at the specified positions and a rice EPSPS gene terminator.
Optionally the desired cassettes also further comprise a drug selection marker gene (e.g ampicillin resistance, kanamycin resistance etc.) a T-DNA Left or Right Border region and (optionally) a scaffold attachment region added 5’ and/or 3’ to the above described construct. The skilled man will recognise that similar methods to those described above can be used to obtain these added components and clone them into the desired positions.
EXAMPLE 11. Transformation of corn lines using an Agrobacterium strain ~ containing a superbinary vector which includes an EPSPS expression cassette between the right and left borders of the T-DNA; selection and regeneration of plant cells and plants which are resistant to glyphosate
Construction of Agrobacterium strain
Bluescript plasmid DNA (e.g. ZEN 7, 8, 17, 19, 21 and 22) is digested with either
Xma 1 or with Xba 1/ Sac 1 and the thus-obtained (~ 5.5- 7 kb) EPSPS-encoding fragment ligated into a position within the cloning site located between the right and left T-DNA borders of similarly restricted pSB1. In the case, for example, of using the Xma 1 fragment of pZEN 8 this ligation creates the plasmid pZEN8SB11 (Figure 16). The construction of plasmid pSB11 and the construction of its parent, pSB21, is described by Komari et al (1996,
Plant J. 10: 165-174). The T-DNA region of pZENS is integrated into the superbinary pSB1 vector.(Saito er al EP 672 752 Al) by a process of homologous recombination (Figure 16) to create the plasmid, pSB1ZENS8. To achieve this the plasmid pZEN8SB11 is transformed into
E. coli strain HB 101 which is then, according to the triple cross method of Ditta et al (1980,
Proc. Natl. Acad. Sci. USA 77: 7347-7351), mated with an Agrobacterium LBA4404 harbouring pSB1 to create the transformed strain of Agrobacterium, LBA4404 (pSB1ZENS) in which the presence of the cointegrate plasmid pSB1ZENS is selected for on the basis of resistance to spectinomycin. The identity of pSB1ZENS is also confirmed on the basis of Sal 1 restriction analysis (Figure 16). LBA4404 strains containing the directly analogous } constructs pSB1ZEN7, pSB1ZEN17, pSB1ZEN19, pSBZEN21 and pSB1ZEN22 are similarly constructed starting from the Xmal fragments of pZEN7, ZEN17, ZEN19, ZEN21 and ZEN22.
Alternatively, using similar methods to those described above, a similar fragment of p ZEN7, ZEN 8 etc is homologously recombined into a position between the right and left borders of the superbinary vector pTOK162 (Fig 1 in US 5591616) to generate a similar set of cointegrate plasmids selected for in Agrobacterium on the basis of combined resistance to kanamycin and spectinomycin.
Agrobacterium strain LBA4404 which has a helper plasmid PAL4404 (having a complete vir region) is available from the American Type Culture Collection (ATCC 37349).
An alternative useful strain is Agrobacterium EHA101 (1986, Hood et al, J. Bacteriol,
168(3): 1283-1290) which has a helper plasmid having the vir region from the strongly virulent strain Agrobacterium tumefaciens A281.
Preparation of Agrobacterium suspensions
Agrobacterium strains LBA4404(pSB1ZENT7), LBA4404 (pSB1ZENS) etc are each streaked onto plates containing ‘PHI-L’ solid medium and cultured at 28 C in the dark for 3 to 10 days.
PHI-L medium is as described on page 26 (Example 4) of WO 98/32326. PHI-L medium made up in double-distilled water comprises 25 mi/I of stock solution A, 25 ml/] of stock solution B, 450.9 ml/ 1 of stock solution C and 50 mg/ | of spectinomycin. Stock solutions are sterilised by autoclaving or filtration. Stock solution A is 60 g/ | K;HPO, and 20 g/ 1 NaH PO, adjusted to pH 7.0 with KOH: stock solution B is 6 g/ | Mg SO4.7H,0, 3 g/
I KCI, 20 g/ 1 NH4Cl, 0.2 g/ 1 CaCl; and 50 mg/ | FeSO,. 7TH,0 : stock solution C is 5.56 g/l of glucose and 16.67 g/ 1 of agar (A-7049, Sigma Chemicals, St Louis, Mo, USA)
Alternatively the Agrobacterium are cultured for 3 -10 d on a plate containing YP medium (5 g/l yeast extract, 10 g/l peptone, 5 g/l NaCl, 15 g/ 1 agar at pH 6.8) as described by Ishida et al (1996, Nature Biotechnology, 14, 745-750) or, alternatively, as described by
Hei et al in US 5591616 (AB medium (Drlica and Kado, 1974; Proc. Natl. Acad. Sci. USA 71:3677-3681)) but, in each case, modified to provide the appropriate antibiotic selection (e.g. containing 50 mg/ ml spectinomycin in the case of Agrobacterium strain .
LBA4404(pSB1ZEN?7) etc. or containing both 50 mg/ ml spectinomycin and 50 mg/ ml kanamycin in the case that Agrobacterium containing a pTOK 162-derived superbinary . vector is used).
Plates of Agrobacterium made as described above are stored at 4 C and used within a month of preparation. For preparation of suspensions a single colony from the master plate is streaked out onto a plate containing, at pH 6.8, 5 g/ | yeast extract (Difco), 10 g/ | peptone (Difco), 5 g/ I NaCl, 15 g/ | agar (Difco) and 50 mg/ | of spectinomycin (or as appropriate for the particular strain of Agrobacterium) . Plates are incubated at 28 C, in the dark for 2d.
Suspensions of Agrobacterium for transformation of plant material are prepared in a similar manner to described in US 5591616. (Using good microbiological practice to avoid contamination of aseptic cultures) 3 X 5 mm loopfuls of Agrobacterium are removed from plates, transferred and suspended in 5 ml of sterile AA liquid medium in a 14 ml Falcon tube. As used here, AA liquid medium at pH 5.2 contains the major inorganic salts, amino
‘WJ 00/66716 PCT/GB00/01559 acids and vitamins defined by Toriyama and Hinata (1985) in Plant Science 41, 179-183), the minor inorganic salts of Murashige and Skoog medium (Murashige and Skoog, 1962 in
Physiol. Plant 15, 473-497), 0.5 g/ 1 of casamino acids (casein hydrolysate), 1 mg/ 1 of 2,4 - dichlorophenoxyacetic acid (2,4-D), 0.2 mg/ | of kinetin, 0.1 mg/ 1 of gibberellin, 0.2M glucose, 0.2M sucrose and 0.1 mM acetosyringone.
Alternatively, suspensions of Agrobacterium for transformation of plant material are prepared in a similar manner to described in WO 98/32326. 3 X 5 mm loopfuls of
Agrobacterium are removed from plates, transferred and suspended in 5 ml of the sterile
PHI-A basic medium as described in Example 4 on page 26 of WO 98/32326 or, alternatively, suspended in 5 ml of the sterile PHI-I combined medium also described in
Example 4 on page 26 of WO 98/32326. In either case 5S ml of 100 mM 3’-5’-Dimethoxy- 4’hydroxyacetophenone is also added. PHI-A basic medium at pH 5.2 comprises 4 g/l of
CHU(NG6) basal salts (Sigma C-1416), 1.0 ml/ 1 of Eriksson's vitamin mix (1000X , Sigma E- 1511), 0.5 mg/l thiamine. HCI, 1.5 mg/ ml of 2,4-D, 0.69g/ | L-proline, 68.5 g/1 sucrose and 68.5 g/ 1 glucose. PHI-I combined medium, also adjusted to pH 5.2 with KOH and filter sterilized, comprises 4.3 g/l of MS salts (GIBCO-BRL), 0.5 mg/ ml nicotinic acid, 0.5 mg/ ml pyridoxine. HCI, 1.0 mg/ ml thiamine. HCL, 100 mg/l myo-inositol, 1 g/1 vitamin assay casamino acids (Difco), 1.5 mg/ ml of 2,4-D, 0.69g/ | L-proline, 68.5 g/1 sucrose and 36 g/ glucose.
Alternatively, suspensions of Agrobacterium for transformation of plant material are } prepared in a similar manner to described by Ishida et al (1996) Nature Biotechnology, 14, 745-750. 3 X 5 mm loopfuls of Agrobacterium are removed from plates, transferred and suspended in 5 ml of LS-inf medium. LS-inf medium (Linsmaier and Skoog, 1965, Physiol.
Plant 18, 100-127) adjusted to pH 5.2 with KOH contained LS major and minor inorganic salts, 0.5 mg/ ml nicotinic acid, 0.5 mg/ ml pyridoxine. HCI, 1.0 mg/ ml thiamine. HCL, 100 : mg/ 1 myo-inositol, 1 g/ I vitamin assay casamino acids (Difco), 1.5 mg/ ml of 2,4-D, 68.5 g/ 1 sucrose and 36 g/ | glucose.
However produced, the suspension of Agrobacterium is vortexed to make an even suspension and the cell population adjusted to between 0.5 x 10° and 2 x 10° cfu/ ml (preferably the lower). | x 10° cfu/ ml corresponds to an OD (1 cm) of ~ 0.72 at 550 nm.
Agrobacterium suspensions are aliquoted into 1 ml lots in sterile 2 ml microcentrifuge tubes and used as soon as possible
Corn lines for transformation
Suitable maize lines for transformation include but are not restricted to, A188, Fl
P3732, F1 (A188 x B73Ht), F1 (B73Ht x A188), F1 (A188 x BMS). Varieties A188, BMS (Black Mexican Sweet) and B73 Ht are obtained from the Ministry of Agriculture, Forestry and Fisheries, which is well known to the skilled man. P3732 is obtained from IWATA
RAKUNOU KYODOKUMIAL Suitable maize lines also include a variety of A188 x inbred crosses (e.g PHI90 x A188, PHN46 x A188, PHPP8 x A188 in table 8 of WO98/ 32326) as well as elite inbreds from different heterotic groups (e.g PHN46, PHP28 and PHJ90 in table 9 of WO98/ 32326).
For example immature embryos are produced from “Hi-II” corn. “Hi-II” is a hybrid between inbreds (A188 x B73) generated by reciprocal crosses between Hi-II parent A and
Hi-1I parent B available from the Maize Genetic Cooperation Stock Center, University of
Illinois at Champaign, Urbana, Illinois). Seeds, termed ‘Hi-II’ seeds obtained from these crosses are planted out in a greenhouse or field. The resulting Hi-II plants are self or cross- pollinated with sister plants
Preparation of immature embryos, infection and co-cultivation
Transformation of immature embryos of corn is carried out by contacting the immature embryos with the suitable recombinant strains of Agrobacterium described above.
An immature embryo means the embryo of an immature seed which is in the stage of . maturing following pollination. Immature embryos are an intact tissue that is capable of cell division to give rise to callus cells that can then differentiate to produce the tissues and . organs of a whole plant. Preferred material for transformation also includes the scutella of embryos which is also capable of inducing dedifferentiated calli with the ability to regenerate normal fertile plants having been initially transformed. Preferred material for transformation thus also includes callus derived from such dedifferentiated immature zygotic embryos or scutella.
Immature corn embryos are isolated aseptically from developing ears as described by
Green and Phillips (1976, Crop. Sci. 15: 417-421) or, alternatively, by the methods of
Neuffer et al (1982, “Growing Maize for genetic purposes” in Maize for biological research, ~~ W.F. Sheridan ed., University Press, University of North Dakota, Grand Forks, North
Dakota, USA). For example, immature corn embryos between 1-2 mm (preferably 1-1.2 mm) long are aseptically isolated from female spikes at 9-12 (preferably 11) d after pollination using a sterile spatula. Typically ears are surface sterilised with 2.63% sodium hypochlorite for 20 min before washing with sterile deionized water and aseptic removal of immature embryos. Immature embryos (preferably ~ 100 in number) are dropped directly into a 2 ml microcentrifuge tube containing about 2 ml of the same medium as used for preparing the suspension of Agrobacterium (the alternatives for which are described above).
The cap of the tube is closed and the contents mixed by vortexing for a few seconds. The medium is decanted off, 2 ml of fresh medium are added and vortexing is repeated. All of the medium is then drawn off to leave the washed immature embryos at the bottom of the tube.
Having prepared the immature maize embryos the next phase of the process, the infection step, is to contact them in with the transformed strain of Agrobacterium.
In one example of this process, the infection step takes place in a liquid medium which includes the major inorganic salts and vitamins of N6 medium (1987, Chu C.C. Proc.
Symp. Plant Tissue Culture, Science Press Peking. Pp 43-50) as described in example 4 of
WO 98/32326. 1.0 ml of suspension of Agrobacterium, prepared as described above in PHI-
A medium is added to the embryos in the microcentrifuge tube and vortexed for about 30s.
Alternatively, 1.0 ml of suspension of Agrobacterium prepared, also as described above, in either PHI-I medium or in LS-inf medium is added.
After standing for 5 minutes the suspension of Agrobacterium and embryos is poured out into a Petri plate containing either 1) PHI-B medium or 2) PHI-J medium or 3) LS-AS medium according to whether the original suspension of Agrobacterium had been prepared in
PHI-A medium, PHI-I medium or LS-inf medium, respectively. The Agrobacterium suspension is drawn off using a Pasteur pipette, the embryos manipulated so that they sit axis-side downwards onto the medium, the plate sealed with parafilm and incubated in the dark at 23-25 C for 3 days of cocultivation. PHI-B medium at pH 5.8 comprises 4 g/l of
CHU(NG) basal salts (Sigma C-1416), 1.0 ml/ I of Eriksson’s vitamin mix (1000X , Sigma E- 1511), 0.5 mg/l thiamine. HCI, 1.5 mg/ ml of 2,4-D, 0.69g/ | L-proline, 0.85 mg/ 1 silver nitrate, 30 g/ | sucrose, 100 mM acetosyringone and 3 g/ 1 gelrite (Sigma). PHI-J medium, also adjusted to pH 5.8 comprises 4.3 g/l of MS salts (GIBCO-BRL), 0.5 mg/ ml nicotinic acid, 0.5 mg/ ml pyridoxine. HCI, 1.0 mg/ mi thiamine. HCL, 100 mg/l myo-inositol, 1.5 mg/ ml of 2,4-D, 0.69g/ | L-proline, 20 g/1 sucrose, 10 g/ 1 glucose, 0.5 g/ 1 MES (Sigma), 100 mM acetosyringone and 8 g/ | purified agar (Sigma A-7049). LS-AS medium (Linsmaier and Skoog, 1965, Physiol. Plant 18, 100-127) adjusted to pH 5.8 with KOH contains LS major and minor inorganic salts, 0.5 mg/ ml nicotinic acid, 0.5 mg/ ml pyridoxine. HCI, 1.0 mg/ ml thiamine. HCL, 700 mg/ 1 L-proline, 100 mg/ I myo-inositol, 1.5 mg/ ml of 2,4-D, 20 g/ 1 sucrose, 10 g/ 1 glucose, 0.5 g/ | MES, 100 mM acetosyringone and 8 g/ | purified agar (Sigma A-7049).
Following the preparation of immature embryos, as described above, an alternative method of achieving transformation is to infect them during and after a period of dedifferentiation as described in US 5591616. Immature embryos are placed on LSD 1.5 solid medium containing LS inorganic salts and vitamins along with 100 mg/ ml casamino ~ 10 acids, 700 mg/1L-proline, 100 mg/ 1 myo-inositol, 1.5 mg/ mi of 2,4-D, 20 g/ | sucrose and 2.3 g/ 1 of gelrite. After 3 weeks at 25 C, calli originating from the scutella are collected in a 2 ml microcentrifuge tube and immersed in 1 ml of Agrobacterium suspension prepared, as described above, in AA medium. After standing for 5 minutes, the resultant calli are transferred to 2N6 solid medium containing 100 uM acetosyringone and incubated in the + dark at 25 C for a 3 day period of cocultivation. 2N6 solid medium comprises the inorganic salts and vitamins of N6 medium (Chu C.C., 1978; Proc. Symp. Plant Tissue Culture,
Science Press Peking, pp 43-50) containing 1 g/ | casamino acids, 2 mg/ 1 2,4-D, 30 g/ sucrose and 2 g/ | of gelrite. ‘Resting and Selection of transformants’ .
Following cocultivation, embryos are, optionally, transferred to a plate containing
PHI-C medium, sealed over with parafilm and incubated in the dark for 3 days for a ‘resting } step’ prior to selection. PHI-C medium at pH 5.8 comprises 4 g/l of CHU(NG6) basal salts (Sigma C-1416), 1.0 ml/ 1 of Eriksson’s vitamin mix (1000X , Sigma E-1511), 0.5 mg/l thiamine. HCI, 1.5 mg/ ml of 2,4-D, 0.69g/ 1 L-proline, 0.85 mg/ | silver nitrate, 30 g/ 1 sucrose, 0.5 g/1 MES, 100 mg/ | carbenicillin and 8 g/ | purified agar (Sigma A-7049). As disclosed in WO 98/32326, the desirability of including this resting step in the overall transformation process varies according to corn line and is a matter of experiment.
For the selection step, about 20 embryos are transferred onto each of a number of } fresh plates containing PHI-D selection medium or LSD 1.5 selection medium , sealed with parafilm and incubated in the dark at 28 C. PHI-D selection medium, adjusted to pH 5.8 with KOH, comprises 4 g/l of CHU(IN6) basal salts (Sigma C-1416), 1.0 ml/ | of Eriksson’s vitamin mix (1000X , Sigma E-1511), 0.5 mg/l thiamine. HCI, 1.5 mg/ ml of 2,4-D, 0.69g/ 1
L-proline, 0.85 mg/ | silver nitrate, 30 g/ 1 sucrose, 0.5 g/ | MES, 100 mg/ | carbenicillin, 8 g/ purified agar (Sigma A-7049) and between 0.1 mM and 20 mM of tissue culture grade N- (Phosphonomethyl)-glycine (Sigma P-9556). LSD 1.5 selection medium, adjusted to pH 5.8 with KOH, comprises LS major and minor inorganic salts (Linsmaier and Skoog, 1965,
Physiol. Plant 18, 100-127), 0.5 mg/ ml! nicotinic acid, 0.5 mg/ ml pyridoxine. HCI, 1.0 mg/ ml thiamine. HCL, 700 mg/ | L-proline, 100 mg/ I myo-inositol, 1.5 mg/ ml of 2,4-D, 20 g/ sucrose, 0.5 g/ 1 MES, 250 mg/ 1 cefotaxime, 8 g/ | purified agar (Sigma A-7049) and between 0.1 mM and 20 mM of tissue culture grade N-(Phosphonomethyl)-glycine (Sigma P- 9556).
Alternatively, in the case that the starting material for selection are calli-derived from immature embryos as disclosed in WO 5591616 then such calli are washed with sterilised water containing 250 mg/ | cefotaxime before culturing on LSD 1.5 selection medium.
The embryos or clusters of cells that proliferate from the immature embryos are transferred (if necessary using a sterile scalpel) to plates containing fresh selection medium at 2 weekly intervals over a total period of about 2 months. Herbicide-resistant calli are then bulked by continued growth on the same medium until the diameter of the selected callus exceeds about 1.5 cm
The concentration of N-(Phosphonomethyl)-glycine in the selection medium is . chosen appropriately to select a desirable number of genuine transformants and is preferably within the range 0.3- 5 mM. Preferably the concentration of N-(Phosphonomethyl)-glycine . used in the selection medium is about 1 mM for the first two weeks of selection and about 3 mM thereafter.
Regeneration of transformants/ propagation and analysis of transformed plant material
The selected calli are regenerated into normal fertile plants according to, for example, the methods described by Duncan et al (1985, Planta, 165, 322-332) by Kamo et al (1985,
Bot. Gaz. 146(3), 327-334) and/or by West et al (1993, The Plant Cell, 5, 1361-1369) and/or by Shillito et al (1989) Bio/ Technol. 7, 581-587.
For example, selected calli of diameter 1.5- 2 cm are transferred to regeneration/ maturation medium and incubated in the dark for about 1-3 weeks to allow the somatic embryos to mature. A suitable regeneration medium, PHI-E medium (WO 98/ 32326) is adjusted to pH 5.6 with KOH and comprises 4.3 g/l of MS salts (GIBCO-BRL), 0.5 mg/ ml nicotinic acid, 0.5 mg/ ml pyridoxine. HCI, 0.1 mg/ ml thiamine. HCL, 100 mg/ | myo-inositol, 2 mg/
glycine, 0.5 mg/ 1 zeatin, 1.0 mg/ ml of indoleacetic acid, 0.1 mM abscisic acid, 100 mg/ carbenicillin, 60 g/ 1 sucrose, 8 g/ 1 purified agar (Sigma A-7049) and, optionally, between 0.02 mM and 1 mM of tissue culture grade N-(Phosphonomethyl)-glycine (Sigma P-9556).
The calli are then transferred to rooting/ regeneration medium and grown at 25 C under either a schedule of 16 h daylight (270 mE m™s™') and 8 h of darkness or under continuous illumination (~ 250 mE m™ sh until such a time as shoots and roots develop.
Suitable rooting/ regeneration media are either LSZ medium as described in the following paragraph (optionally containing no phosphonomethylglycine) or PHI-F medium at pH 5.6 which comprises 4.3 g/l of MS salts (GIBCO-BRL), 0.5 mg/ ml nicotinic acid, 0.5 mg/ ml pyridoxine. HCI, 0.1 mg/ ml thiamine. HCL, 100 mg/l myo-inositol, 2 mg/ I glycine, 40 g/ sucrose and 1.5 g/ 1 gelrite.
Alternatively, selected calli are transferred directly to LSZ regeneration medium adjusted to pH 5.8 with KOH and comprising LS major and minor inorganic salts (Linsmaier and Skoog, 1965, Physiol. Plant 18, 100-127), 0.5 mg/ ml nicotinic acid, 0.5 mg/ ml = pyridoxine. HCI, 1.0 mg/ ml thiamine. HCL, 700 mg/ | L-proline, 100 mg/ | myo-inositol, 5 mg/ ml of zeatin, 20 g/ | sucrose, 0.5 g/ | MES, 250 mg/ | cefotaxime, 8 g/ | purified agar (Sigma A-7049) and, optionally, between 0.02 mM and 1 mM of tissue culture grade N- (Phosphonomethyl)-glycine (Sigma P-9556) is used. After a period of incubation in the dark plates are subject to illumination (continuous or light/day as above)and plantlets regenerated. }
Small plantlets are transferred to individual glass tubes containing either PHI-F medium or half strength LSF medium at pH 5.8 comprising LS major salts (Linsmaier and
Skoog, 19635, Physiol. Plant 18, 100-127) at half strength, LS minor salts, 0.5 mg/ ml nicotinic acid, 0.5 mg/ ml pyridoxine. HCI, 1.0 mg/ ml thiamine. HCL, 100 mg/ | myo- inositol, 20 g/ 1 sucrose, 0.5 g/ 1 MES, 8 g/ 1 purified agar (Sigma A-7049).and grown on for about another week. Plantlets are then transferred to pots of soil, hardened off in a growth chamber (85% relative humidity, 600 ppm CO; and 250 mE m™ s™') and grown to maturity in a soil mixture in a greenhouse:
The first (To) generation of plants obtained as above are self fertilised to obtain second generation (T1) seeds. Alternatively (and preferably) the first generation of plants are reciprocally crossed with another non-transgenic corn inbred line in order to obtain second generation seeds. The progeny of these crosses (T1) are then expected to segregate 1:1 for the herbicide resistance trait. T1 seeds are sown, grown up in the glass house or field and the level of resistance, inheritance of resistance and segregation of resistance to the herbicide glyphosate through this and subsequent generations assessed by the observation of differential plant survival, fertility, and symptoms of necrosis in tissue following spray treatment of with glyphosate (suitably formulated and, optionally, as a salt) at a range of rates between 25 and 2000 g/ ha and at a range of growth stages between and including V2 and V8 (or, alternatively, at 7-21 days post germination). These assessments are made relative to susceptible segregants and relative to similar, untransformed lines of corn which do not comprise genes of the present or similar inventions capable of conferring resistance to glyphosate. Transgenic lines which exhibit resistance to glyphosate are selected and again selfed or backcrossed to a non-transgenic inbred.
At al stages in the above process tissue samples of transformed callus, plantlets, TO and T1 plant material are optionally taken and analysed by 1) Southerns and PCR in order to indicate the presence , copy number and integrity of transgenes, 2) Northern (or similar) analysis in order to measure expression of MRNA from transgenes, 3) quantitative Western analysis of SDS gels in order to measure expression levels of EPSPS and 4) measurement of
EPSPS enzyme activity levels in the presence and absence of glyphosate in order to assess more accurately how much of the EPSPS which is expressed derives from the transgene.
Such methods of analysis are well known in the art. Suitable methods to test for the } presence, integrity and expression of the transgene by PCR, for carrying out Southern analysis, for the cloning and expression of mature rice EPSPS in E.coli, for the purification } of rice EPSPS, for the generation of polyclonal antibodies to purified rice EPSPS, for
Western analysis of EPSPS levels in callus and in plant tissues and for the measurement of
EPSPS activity levels in plant-derived extracts at a concentration of glyphosate which discriminates between the endogenous glyphosate-susceptible EPSPS and the glyphosate- resistant product of the EPSPS-encoding transgene are described in more detail below in
Examples 17-20.
EXAMPLE 12. Transformation of corn lines by bombardment with particles coated with DNA which includes an EPSPS expression cassette; selection and regeneration of plant cells and plants which are resistant to glyphosate
In a further example, friable embryogenic callus derived from immature maize embryos is initiated on a solid medium and transformed biolistically. Similar to the process described in example 11, transformed callus is then selected on the basis of differential growth rate in medium containing a range of concentrations of glyphosate. Resistant callus is selected and regenerated to provide To plantlets which are transferred to pots, grown to maturity and self or cross fertilised in the glasshouse. The progeny seed (T1) are then grown up to provide further generations of plants which are assessed for resistance to glyphosate and analysed for transgene presence, integrity and expression as described in example 11.
Initiation of callus from immature embryos
Friable embryogenic Type II callus suitable for transformation is derived from immature embryos of, for example, A188 X B73 corn. Alternative inbred such as B73- derived and hybrid lines of corn can be also used including, for example, those listed in
Example 11. Immature embryos of maize between 1-2 mm long are isolated aseptically from female spikes at, typically, about 11 d after pollination using the methods indicated in example 11.
Immature embryos are plated onto, for example, onto a N6-based medium (Chu et al, 1975, Scientia Sinica, 18, 659-668) adjusted with KOH to pH 5.8 containing 1mg/ 1 2,4-D, 2.9g/1L-proline, 2 mg/ | L-glycine, 100 mg/ I of casein hydrolysate, N6 major salts, N6 minor salts, N6 vitamins, 2.5 g/ | gelrite (or 2 g/ 1 ‘Gelgro’) and 20 g/ 1 sucrose. Alternative suitable media include, for example, a similar medium but containing MS salts (Murashige and Skoog, 1962, Physiol. Plant, 15, 473-497) in place of N6 salts. Alternatively, the medium may contain ~ 10 mg/ | dicamba in place of 2,4-D. :
Immature embryos are incubated in the dark on the above medium at ~ 25 C in order to initiate callus. Type II callus material is selected by visual selection of fast growing friable i embryogenic cells by methods known in the art and as described for example in WO 98/ 44140. For example, suitable recipient cells are selected manually by choosing preferred cells which may be at the surface of a cell cluster and further identifiable by their lack of differentiation, small size and high nucleus/ cytoplasm volume ratio. A suspension culture is initiated from tissue within the callus which appears the least differentiated , softest and most friable. Tissue with this morphology is transferred to fresh plates of media about 8- 16 d after the initial plating of the immature embryos. The tissue is then routinely subcultured every 14-21 d by taking on ~ 10% of pieces which reach approximately a gram. At each step only material with the desired type II or type III morphology is subcultured on.
Preparation of cell suspension cultures
Preferably within 6 months of the above-described callus initiation, dispersed suspension cultures are initiated in liquid media containing suitable hormones such as 2,4-D and NAA optionally supplied in the form of slow-release hormone capsule treatments as described for example in examples 1 and 2 of US 5550318. Optionally, hormone levels within the cultures are maintained by occasional spiking with fresh hormone supplement.
Suspension cultures are initiated, for example, by adding approximately 0.5 g of callus tissue to a 100 ml flask containing 10 ml of suspension culture medium. Every 7days, the culture is further subcultured by transferring, by use of a sterile wide-ended pipette, 1 ml of settled cells and 4 ml of conditioned medium to a fresh flask containing fresh medium. Large aggregates of cells unable to pass through the pipette tip are excluded at each subculturing step. Optionally, suspension cultures are passed through a suitable sieve (e.g. ~ 0.5-1 mm mesh) at each subculturing step. After 6- 12 weeks the culture becomes dispersed. Suitable cell suspension culture media include for example, a medium adjusted to pH 6.0 containing
Murashige and Skoog (1962) major and minor salts (optionally modified to contain a reduced level, 1.55 g/ 1, of ammonium nitrate), 30 g/l sucrose, 0.25 mg/ 1 thiamine, 10 mg/ dicamba, 25 mM L-proline, 200 mg/ I casein hydrolysate, 100 mg/ 1 myo-inositol, S00 mg/ 1 potassium sulphate and 400 mg/ | potassium hydrogen phosphate. Alternatively, in place of ) dicamba, cell suspension medium contains 2,4-D and/or NAA.
Cryopreservation of cell suspension cultures } Optionally, suspension cultures obtained as described above, are cryopreserved using cryoprotectants and methods described for example in example 2 of US 5550318.
Cryopreservation entails adding cryoprotectant at ice temperature to pre-cooled cells, also at ice temperature, in a stepwise manner over a period of one to two hours. The mixture is maintained at ice temperature and the eventual volume of cryoprotectant is equal to the volume of cell suspension. The final concentrations of cryoprotectants are, for example, 10% dimethylsulfoxide, 10% polyethylene glycol (6000 Mw), 0.23 M L-proline and 0.23 M glucose. After a 30 min period of equilibration at ice temperature the mixture is divided into ~ 0.5 ml aliquots, transferred to 2 ml microcentrifuge tubes, and cooled slowly at a rate of 0.5 C/ min down to a temperature of -8 C. Following a period for ice nucleation, the sample is further cooled slowly down to -35 C and then plunged into liquid nitrogen. When required for use, frozen samples are thawed by first bathing them in their containers in water at ~ 40 C for 2 min and then allowing them to slowly thaw completely. The mixture of cells and cryoprotectants 1s then pipetted onto a filter laid over a layer of BMS ‘feeder’ cells at 25 C.
Once the thawed tissue begins to grow it is transferred back to fresh solid culture medium and, once established (within 1 to 2 weeks) is further transferred into cell suspension culture medium. Once growth in liquid suspension culture is re-established the cells are used for transformation.
Particle-mediated transformation
Plasmid pIGPD9-derived DNA (Figure 12) containing Xmal EPSPS expression cassettes (i.e. pZENT7i, ZENS, etc.) is purified, bulked up (e.g by anion exchange chromatographic or CsCl, gradient densitometric isolation of plasmid DNA from cells of a suitable HisB- Rec A- host strain of E.coli (e.g. DH50a.: hisB-) after growth to stationary phase in a minimal 5xA medium (K>HPO, 52.5g, KH,PO, 22.5g, (NH4)2S04 Sg and sodium citrate.2H»O 2.5g per litre) and provided as a concentrated solution (preferably ~ 1 mg/ ml) in sterile water. DNA is provided as a circular plasmid DNA or, alternatively is restricted with Xma 1 to provide a linear EPSPS-expression cassette-containing fragment and used following purification by agarose gel electrophoresis and electroelution.
Suitable apparatus for bombardment is, for example, the Biorad PDS1000 Helium gun. The dish is placed 5-6 cm below the stopping screen used to stop the Kapton macroprojectile. The DNA construct is precipitated onto tungsten or gold particles with an - average diameter of ~ 1.0 um in a similar manner to that described by Klein et al 1987,
Nature, 327, 70-73. For example, 1.25 mg of tungsten or gold particles (pre-washed in : ethanol at 65 C for 12 h) are mixed, in successive order, with ~ 20-30 mg of DNA, 1.1 M
CaCl; and 8.7 mM spermidine to a final volume of ~ 0.6 ml. The mixture is vortexed for 10 min at 0-4 C, subject to low speed centrifugation (~ 500g) for 5 min and the bulk of the supernatant decanted off to leave the tungsten particles suspended in a final volume of ~ 30 ml. 1- 10 pl aliquots are pipetted onto the macroprojectile of the particle gun.
Suspension cultures derived from type IT and/or type Ili callus are maintained in culture for 3-5 months (or, alternatively, recovered from cryopreservation) , freshly : subcultured and then sieved through a ~ 0.5-1 mm stainless steel mesh. Approximately 0.5 ml packed cell volume of cells recovered from the filtrate is then pipetted onto 5 cm paper filters and vacuum dried before transfer to a petri dish containing a stack of three 7 cm paper filters moistened with suspension culture medium. Each plate of suspension cells is centred onto the sample plate tray, the petri dish lid removed and bombarded twice at a vacuum of 28 inches of mercury. 0.1 or 1.0 mm screens are optionally placed about 2.5 cm below the stop plate in order to ameliorate injury to the bombarded tissue. After bombardment the plant cells are removed from the filter, resuspended back into cell suspension culture medium and cultured for 2-21 days. Alternatively, the bombarded callus is transferred, plate to plate, onto to a plate containing a similar solid medium (for example containing 8g/ | of purified agar) and similarly cultured at ~ 25 C in the dark.
Selection of transformants
Following transformation, cells growing unselected in liquid or solid culture are transferred to filters and overlayed onto solid medium containing a range (0.1 - 20 mM) of selecting concentrations of tissue culture grade N-(phosphonomethyl) glycine (Sigma).
Suitable solid selection media include media, adjusted to pH 5.8 or 6.0 with KOH, containing either MS or N6 salts (such as those described above for callus initiation or, with suitable addition of agar, those described above for growth of cells in liquid suspension) and
N-(phosphonomethyl) glycine . Suitable selection media also include, for example, the selection media described in example 11 but, in this case, modified so as to lack antibiotics.
Transformed calli expressing the resistant EPSP synthase enzyme are selected on the basis of their growth at concentrations inhibitory to similar preparations of untransformed cells.
Growing clumps are subcultured on to fresh selective medium. Preferably the concentration of N-(Phosphonomethyl)-glycine used in the selection medium is about 1 mM for the first two weeks of selection and about 3 mM thereafter. After 6-18 weeks putative resistant calli are identified and selected.
Regeneration of transformants/ Propagation and Analysis of transformed plant material
The selected calli are regenerated into normal fertile plants according to, for example, the methods described by Duncan et al (1985, Planta, 165, 322-332) by Kamo et al (1985,
Bot. Gaz. 146(3), 327-334) and/or by West et al (1993, The Plant Cell, 5, 1361-1369) and/or by Shillito et al (1989) Bio/ Technol. 7, 581-587.
For example, plants are efficiently regenerated by transferring the embryogenic callus to Murashige and Skoog medium adjusted to pH 6.0 containing 0.25 mg/ 12,4-D, 10 mg/ 1 6- benzyl-aminopurine and, optionally, 0.02 to 1 mM N-(phosphonomethyl) glycine. After ~ 2 weeks tissue is transferred to a similar medium but lacking hormones. Optionally the hormone level is decreased step wise through more transfers and over a longer period of time up to 6-8 weeks. Shoots which develop after 2-4 weeks are transferred to MS medium containing 1% sucrose and solidified with 2g/ 1 Gelgro into which they then root.
Alternatively methods and media used for regeneration are as in example 11 except that the media used do not contain antibiotic.
Methods for growing plants to maturity, for the further propagation of plants through generations, for analysis of the inheritance of resistance to glyphosate and for analysis of the presence, integrity and expression of the EPSPS transgene are as described in example 11.
EXAMPLE 13. Transformation of corn lines with DNA which includes an EPSPS expression cassette coated onto silicon carbide whiskers: selection and regeneration of plant cells and plants which are resistant to glyphosate
In a further example, maize lines including, for example, hybrid lines having the genotype A188 x B73 are prepared as cell suspensions and transformed by contacting the cells with silicon carbide whiskers coated with DNA using methods essentially as described by Frame et al (1994, Plant J. 6, 941-948). As described in the previous examples, the transformed callus so generated is selected on the basis of differential growth rate in medium : containing a range of concentrations of glyphosate, regenerated into plantlets (To) which are grown to maturity and either self or cross fertilised to provide progeny seed (T1) for further breeding. Plants and plant material is assessed for resistance to glyphosate and analysed for transgene presence, integrity and expression as described in the previous examples. }
Initiation of callus from immature embryos, preparation of cell suspension cultures
Maize cell suspensions suitable for transformation are optionally cryopreserved and : provided in the same manner as described in example 2
Transformation
Plasmid pIGPD9-derived DNA (Figure 12) containing Xmal EPSPS expression cassettes (e.g. pZENT7i, ZENSI etc.) is purified, bulked up (e.g by anion exchange chromatographic or CsCl, gradient densitometric isolation of plasmid DNA from cells of a suitable HisB-,Rec A- host strain of E.coli (e.g. DH50.: hisB-) after growth to stationary phase in a minimal 5xA medium (K,HPO4 52.5g, KH,PO4 22.5g, (NH4)2SO04 Sg and sodium citrate.2H,0 2.5g per litre) and provided as a concentrated solution (preferably ~ 1 mg/ ml) in sterile water. DNA is provided as a circular plasmid DNA or, alternatively is restricted with Xma 1 to provide a linear EPSPS-expression cassette-containing fragment and used following purification by agarose gel electrophoresis and electroelution.
Transformation is carried out exactly as described by Frame er al 1994. Alternatively the procedure is somewhat modified as described below.
Cells grown in liquid culture in cell suspension medium one day after subculturing are allowed to settle out in a shake flask. Spent medium is decanted and drawn off and 12 ml of N6 medium at pH 6.0 (Chu et al 1975) modified to contain 6 mM L-proline, 20 g/ sucrose, 2 mg/12,4-D, 0.25 M sorbitol and 0.25M mannitol is added per 4 ml packed cell volume. The flask is returned to the shaker (rotary shaken at 125 rpm and incubated at 26-28
C) for 45 min. At the end of this period 1 ml aliquots of cell suspension are removed, using a wide bore pipette, into a series of sterile microcentrifuge tubes. After allowing the cells in each tube to settle out, 0.6 ml of the spent medium supernatant is then removed to leave most of the remaining content as settled cells. 50 mg of silicon carbide whiskers (Silar SC-9 whiskers, Advanced Composite Materials Corp., Greer, SC. USA) are suspended by vortexing in 1 ml of the modified N6 medium described above. 40 pl of these suspended whiskers and 25 mg of the plasmid or linear DNA including the EPSPS expression cassette are then added to each tube of settled cells. The tubes are finger vortexed 2-3 times, mixomated (in a Mixomat dental amalgam mixer (Degussa, Ontario, Canada) for 1 second and then 0.3 ml of N6 medium (modified as described above) is added to each microcentrifuge tube. The suspended cells are then plated (200 pl/ plate)out onto a filter . disc overlying solid N6 medium: (the same as the modified N6 medium described above but lacking sorbitol, lacking mannitol and containing 30 g/ I sucrose and 3 g/ | of gelrite). Each plate is then wrapped with Urgopore tape (Stelrico, Brussels) and left to incubate in the dark for 1 week at 26-28 C.
Selection of transformants
Transformed callus is selected as described in example 12 or, alternatively, as described in Frame et al 1994 except that N-(phosphonomethyl)glycine is used, at a range of concentrations between 1 and 5 mM in place of the bialaphos specified in the Frame et al publication.
Regeneration of transformants/ propagation and analysis of transformed plant material
Plants are regenerated, propagated, and bred as described in example 12. Plants are analysed for resistance to glyphosate and plant material is analysed for transgene presence, integrity and expression as described in example 12
TABLE 2. Expression of EPSPS transgene in regenerable callus following transformation using silicon carbide Whiskers
The table shows EPSPS enzyme assay (+/- 100 pM glyphosate at 100 uM PEP) results based upon enzyme assays of extracts of stably transformed callus of regenerable
A188 x B73 regenerable corn, transformed by Whiskers with ZEN8i DNA. Each callus line represents a single event which is assayed in duplicate. The ratio of the true (allowing for ~ 8% inhibition) tolerant enzyme activity expressed by the transgene to endogenous susceptible activity (>98% inhibition + glyphosate) is calculated. The mutant EPSPS is expressed relatively strongly in some lines, notably lines 90928sr2-1 and 90921sq1-1, where, allowing for the reduced Vmax of the tolerant enzyme relative to the w/t (about a third) it can be estimated that the tolerant enzyme is expressed at 3-15X the normal level of endogenous
EPSPS (this calculation is complicated by the fact that, in some selected calli, expression of the transgene occurs alongside an apparent ~ 2-3X increase in the background expression of the susceptible endogenous enzyme). The same extracts were also analysed by Westerns (in this case using polyclonal antibodies raised to purified Brassica napus EPSPS) and the amount of EPSPS quantitated on the basis of reaction with a standard curve of purified rice
EPSPS. The Western data are expressed as fold increase in total EPSPS amount relative to untransformed corn callus. In good agreement with the enzyme data, the Western data indicate a high level of EPSPS expression in, for example, lines 90928sr2-1 and 90921sq1- -
Event. DNA Measured activity Total Activity (nmole/ Ratio of Western
Line# Construct (nmol/ min/ mg) + min / mg) in absence of (true) analysis of 160uM glyphosate glyphosate tolerant/ [epsps] (true tolerant sensitive (X-fold) activity = measured EPSPS relative to x 1.08) activity control '90928te5-1 PHS 417 10.2 12 6 4.11 16.93 90928te5-3 PHS 2.01 12.59 1:5 6 2.16 14.22 90921sb3-1 PHS 2.8 13.93 1:1.5-3.1 8 7.08 20.15 90921sq1-1 PHS 8.00 20.18 1:0.9 10 7.79 15.82 90928sal-1 PHB 0.39 5.90 1:10 0.60 9.91 90928sr2-1 PHS 21.67 42.55 1:0.9 17 21.66 49.79 90928sd2-1 PHS 6.69 15.16 1:1 10 ] 6.28 16.8
EXAMPLE 14. Transformation of rice lines using an Agrobacterium strain containing a superbinary vector which includes an EPSPS expression cassette between the right and left borders of the T-DNA ; selection and regeneration of plant cells and plants which are resistant to glyphosate
In a further example, scutella are isolated from mature seeds of suitable lines of rice (including, for example, varieties Koshihikari, Tsukinohikari and Asanohikari) dedifferentiated and the callus thus-obtained transformed by infection with Agrobacterium.
Following selection and regeneration, transgenic plantlets (To) are obtained which are grown to maturity and either self or cross fertilised to provide progeny seed (T1) for further breeding. Plants and plant material are assessed for resistance to glyphosate and analysed for transgene presence, integrity and expression as described in the previous examples. As an alternative to the methods described below the methods described in example 1 of US 5591616, suitable adapted so that glyphosate rather than hygromycin is used for selection, are used.
Construction of Agrobacterium strain; Preparation of Agrobacterium suspension
A strain of Agrobacterium containing superbinary vector having the desired EPSPS expression cassette between the right and left borders is constructed (using electroporation to transform Agrobacterium with plasmid DNA) as described in example 11. Suspensions are prepared according to the methods described in example 11. Alternatively, the transformed . strain of Agrobacterium is grown for 3 days on AB medium (Chilton et al, 1974, Proc. Natl.
Acad. Sci. USA, 71, 3672-3676) containing appropriate antibiotic selection (e.g. 50 mg/ | : spectinomycin in the case of LBA4404 (pSB1ZENS etc)) and looped off of the plate to form a suspension in AAM medium (Hiei et al, 1994, The Plant Journal, 6(2), 271-282) at a density of 1-5 x 10° cells/ ml.
Rice cultivars, preparation of callus from scutella :
Rice cultivars are, for example Oryza sativa L. Tsukinohikari, Asanohikari and
Koshihikari.
Mature seeds are dehusked, surface sterilized by washing in 70% ethanol and then soaked for 30 minutes in 1.5% NaOCl. After rinsing in sterile water they are cultured at 30
C, in darkness for 3 weeks on 2N6 medium at pH 5.8 which contains the major salts, minor salts and vitamins of N6 medium (Chu 1978 in Proc. Symp. Plant Tissue Culture., Peking:
Science Press, pp 43-50) 30 g/ 1 sucrose, 1 g/l casein hydrolysate, 2 mg/12,4-D and 2 g/
gelrite. Proliferated callus derived from the seed scutella is subcultured for 3-7 days on fresh 2N6 medium. Growing callus (1-2 mm in diameter) is selected, suspended in 2N6 liquid medium (without gelrite) and cultured in flasks, in darkness on a rotary shaker at 125 rpm and at 25 C. The medium is changed every 7 days. Cells growing in log phase after 3- 4 transformations are used for transformation.
Infection, transformation and selection
Suspended rice callus cells are allowed to settle out of suspension and then resuspended in the suspension of Agrobacterium, left in contact for several minutes and then, again, allowed to settle out and, without rinsing, plated out onto 2N6-AS medium (2N6 medium adjusted to pH 5.2 and containing 10 g/ I D-glucose and 100 pM acetosyringone) and incubated in the dark at 25 C for 3-5 days. Growing material is rinsed throroughly with 250 mg/ | cefotaxime in sterile water and then transferred onto 2N6-CH medium (2N6 medium adjusted to pH 5.8 with KOH containing 250 mg/ | cefotaxime and 0.5 - 5 mM tissue culture grade N-(phosphonomethyl) glycine) or, alternatively, 2N6K-CH medium (2N6 medium modified as described by Hiei et al 1994 but, in place of hygromycin, containing 0.5 - 5 mM tissue culture grade N-(phosphonomethyl) glycine) and cultured for 3 weeks in the dark at 25C. Proliferating colonies are subcultured onto a second plate of selective medium for a further period of 7-14 days. . Regeneration and analysis of plants
Growing colonies are plated onto a regeneration medium at pH 5.8 containing half } strength N6 major salts, N6 minor salts, N6 amino acids, vitamins of AA medium (Chilton er al 1974), 1 g/ | casein hydrolysate, 20 g/ I sucrose, 0.2 mg/ 1 napthaleneacetic acid, 1 mg/ kinetin, 3 g/ | gelrite and, optionally, 0.04-0.1 mM N-(phosphonomethyl)glycine. These plates are incubated at 25 C and kept under continuous illumination (~ 2000 lux). As described in example 1 regenerated plants are eventually transferred to soil in pots and matured in a greenhouse.
Plants are propagated, and bred (for example the transgenic plants are selfed) essentially as described in example 11. Plants are analysed for resistance to glyphosate and plant material is analysed for transgene presence, integrity and expression essentially as described in example 11.
EXAMPLE 15. Transformation of wheat lines with DNA which includes an EPSPS expression cassette by use of microprojectile bombardment; selection and regeneration of plant cells and plants which are resistant to glyphosate
In a further example, immature embryos are isolated from suitable lines of wheat (including, for example, spring wheat cv BobWhite, and Jaggar) incubated on hormone( 2,4-
D) -containing medium for 2 days and transformed by bombardment with DNA-coated particles. Following a period for recovery and continued growth of callus, callusing embryos are subcultured through a series of media containing a fixed level of glyphosate and (serially diluted) decreasing levels of 2,4-D such that somatic embryogenesis is induced. The selected material is regenerated to form shoots on a medium also containing glyphosate, transferred to rooting medium and, as in the previous maize-related examples, regenerated into plantlets (To) which are grown to maturity and either self or cross fertilised to provide progeny seed (T1) for further breeding. Plants and plant material are assessed for resistance to glyphosate and analysed for transgene presence, integrity and expression as described in the previous examples. As an alternative to the methods described below the methods described in example 1 of US 5631152 are used.
Preparation of immature embryos
Wheat plant lines (for example spring wheat Triticum aestivum cv BobWhite) are grown to maturity in the greenhouse and caryopses isolated at 11 - 15 postanthesis. } 20 .Caryopses are surface sterilised by treatment for 15 minutes in 5%NaOCl and then washed repeatedly in sterile water. Immature embryos are aseptically isolated onto 3cm squares of nylon netting (mesh size 1.5 mm) overlying A2 medium . A2 medium adjusted to pH 5.8 is 4.32 g/ 1 Murashige and Skoog salts, 20 g/ 1 sucrose, 0.5 g/ 1 L-glutamine, 2 mg/ 1 2,4-D, 100 mg/ 1 casein hydrolysate, 2 mg/ 1 glycine, 100 mg/ 1 myo-inositol, 0.5 mg/ I nicotinic acid, 0.1 mg/l thiamine. HCl and 2.5 g/ | gelrite. Embryos are arranged into a solid 2.5 cm disc, comprising approx. 50 in number. Plates are sealed with leukopore tape and incubated at 25°C in the dark for 2 days. Four hours prior to bombardment embryos are transferred onto plates containing fresh A2 medium supplemented with 36.44 g/ 1 D-sorbitol and 36.44 g/ 1 D- mannitol. The embryos are transferred from plate to plate by means of the nylon net upon which they sit. The embryos sit on this increased osmotic strength medium for 4 h at 25°C in the dark before being bombarded.
t -39-
Particle-mediated transformation
Plasmid pIGPD9-derived DNA (Figure 12) containing Xmal EPSPS expression cassettes (i.e. pZEN7i, ZENSI etc.) is purified, bulked up (e.g by anion exchange chromatographic or CsCl, gradient densitometric isolation of plasmid DNA from cells of a suitable HisB-,Rec A- host strain of E.coli (e.g. DH5c.: hisB-) after growth to stationary phase in minimal 5xA medium (K;HPO, 52.5g, KH,PO, 22.5g, (NH4)2504 Sg and sodium citrate.2H,O 2.5g per litre) and provided as a concentrated solution (preferably ~ 1 mg/ ml) in sterile water. DNA is provided as a circular plasmid DNA or, alternatively is restricted with Xma 1 to provide a linear EPSPS-expression cassette-containing fragment following purification by agarose gel electrophoresis and electroelution.
Particles are prepared and coated with DNA in a similar manner to that described by
Klein er al 1987, Nature, 327, 70-73. Preparation of DNA-coated particles and operation of the particle gun is as described in example 12. Alternatively, the details are as follows. For example, 60 mg of gold or tungsten particles (~ 1.0 um) in a microcentrifuge tube are washed repeatedly in HPLC-grade ethanol and then, repeatedly, in sterile water. The particles are resuspended in 1 ml of sterile water and dispensed into 50 pl aliquots in microcentrifuge tubes. Gold particles are stored at 4 C, tungsten particles at - 20 C. 3 mg of DNA are added to each aliquot of (defrosted) particles and the tubes are vortexed at top speed. Whilst . maintaining near continuous vortexing, 50 pl of 2.5M CaCl; and 20 pl of 0.1M spermidine is added. After 10 minutes of further vortexing, samples are centrifuged for 5 seconds in an . eppendorf microcentrifuge, the supernatant is drawn off and the particles washed in successive additions of HPLC-grade ethanol. The particles are thoroughly resuspended in 60 ul of ethanol and then dispensed in 10 pl aliquots onto the surface of each kapton membrane macrocarrier to be used in the PDS1000 particle gun
Components of the PDS1000 particle gun are surface sterilised by immersion in 70% ethanol and air-drying. Target plates prepared, as described above, with ~ 50 embryos arranged into an ~ 2.5 cm disc are placed 6 cm from the stopping screen. 1100 psi rupture discs are then used for bombardment. Each plate is bombarded once or twice.
Bombarded plates are sealed with pore tape and maintained at 25 C in the dark for ~ 16h. Embryos dislodged from the surface of the medium by the helium shock wave are recovered and also incubated overnight on fresh plates of the same mannitol and sorbitol-
supplemented A2 medium. The bombarded embryos are then transferred to fresh plates of
A2 medium and incubated for 1 week at 25 C in the dark prior to selection.
Selection and Regeneration of Transformants
After this recovery period callusing embryos are removed from the nets and transferred to A2 2P medium (A2 medium, adjusted to pH 5.8 containing 2 mM N- (phosphonomethyl)glycine), at a density of 20 explants / plate. After one week on A2 2P medium, calli are removed to Al 2P medium (A2 medium containing only 1.0 mg /1 2,4-D and 2 mM N-(phosphonomethyl)glycine) for 2 weeks and thence to A 0.5 2P medium (A2 medium containing only 0.5 mg /1 2,4-D and 2 mM N-(phosphonomethyl)glycine) for a further two weeks. Optionally, the 2 week incubation periods are reduced to 1 week and/or the middle step of incubation on Al 2P medium is omitted. Optionally, the selecting concentration of N-phosphonomethylglycine is between 0.5 and 10 mM although 2 mM is preferred. The overall time for this period of callus induction with descending levels of 2,4-
D in the medium is 2- 10 weeks, preferably 3-6 weeks and most preferably ~ 4 weeks.
To encourage maximum shoot growth and to discourage root development the calli are then transferred to Z medium. Z medium is A2 medium but containing 10 mg/ | zeatin in place of 2,4-D and also containing 0.1 mM N-(phosphonomethyl)glycine. Optionally, N- (phosphonomethyl)glycine is in the range 0.04 - 0.25 mM. Regenerating calli are maintained on this medium for a period of 3 weeks before subculture, at which point well } developed shoots are excised. As only one event is likely to be produced on a single callus (which represents a single embryo), the entire callus is removed to a fresh plate and . maintained with the excised shoot(s) to ensure multiple clones arising from the same callus do not get counted as separate events. Calli with only partially developed shoots or without regenerating sectors are returned to Z medium for a further 3 weeks. At the end of this period non regenerating calli are discarded.
Shoots are maintained on Z medium until 4 or more well-developed leaves (extending to ~ 2 cm in length) have formed. The regenerating plant material is then carefully transferred to plastic tubs containing 0.5MS medium. 0.5 MS medium at pH 5.8 is 2.16 g/ 1 of Murashige and Skoog salts, 15 g/ 1 sucrose, 2.5 g activated charcoal, 2.5 g/ 1 gelrite, 1 mg/ 1glycine, 50 mg/l myo-inositol, 0.25 mg/ I nicotinic acid, 0.25 mg/ | pyridoxine. HCL, 0.05 mg/ | thiamine.HC| and 0.1 mM N-(phosphonomethyl)glycine (optionally 0.0-0.25 mM).
N -4] -
Once plants have rooted they may be potted into soil and weaned, or removed to individual glass boiling tubes containing 0.5MS (with no N-(phosphonomethyl)glycine) and 2.5 g/l charcoal. It is preferred to have charcoal present in the rooting medium to adsorb any remaining PGRs or selection chemical transferred with the plantlet, and to create a dark rooting environment thereby avoiding physiologically aberrant green roots.
Callus induction and the first week of regeneration occurs at 25°C in the dark. The second week of regeneration occurs at low light at 25°C, then subsequent weeks at approx. 2500 lux on a 16 hour photo period.
Propagation, breeding and analysis of transformed plant material
Methods of producing T1 and further progeny are all well known in the art and essentially as described in the previous examples. Methods for analysis of the inheritance of resistance to glyphosate and the presence, integrity and expression of transgenes are as in the previous examples
EXAMPLE 16. Transformation of wheat lines with DNA which includes an EPSPS expression cassette by electroporation of protoplasts; selection and regeneration of plant cells and plants which are resistant to glyphosate
In a further example, plasmid or linear DNA comprising an EPSPS expression cassette and identical to that used in examples 12, 13 and 15 is used for direct transformation of protoplasts of a line of wheat capable of regeneration into fertile plants (¢f US 5231019).
Isolated protoplasts of wheat, preferably from leaf tissue or cells in culture (¢f Gamborg, O.L. } and Wetter, L.R., Plant Tissue Culture Methods, 1975, 11-21) are prepared at ~ ca 2 X 10° protoplasts/ml in 0.4M mannitol at pH 5.8. To this suspension are added first, 0.5 ml of 40% w/v polyethylene glycol (PEG) of molecular weight 6000 in modified F medium (Nature (1982), 296, 72-74) at pH 5.8 and, second, 65 ml of water containing 15 mg of the desired plasmid or linear DNA and 50 mg of calf thymus DNA. The mixture is incubated together for 30 min at 26 C, occasionally agitated and subsequently diluted into F medium ( Nature (1982), 296, 72-74). The protoplast are isolated by low-speed centrifugation, taken up in 4 ml of CC culture medium (Potrykus, Harms, Lorz, (1979) Theor. Appl. Genet., 54, 209-214) and incubated in the dark at 24 C.
Alternatively, and in addition to treatment with PEG, transformation of cereal protoplasts is carried out using further steps of heat shock and/or electroporation (Neumann,
E. etal (1982), the EMBO I., 7, 841-845). Thus, for example, wheat protoplasts are incubated in an aqueous solution of DNA and mannitol, heated to 45 C for 5 min and then cooled to 0 C over a period of 10 seconds. Then polyethylene glycol is added (Mr 3K -8K) until the final concentration is ~ 8% w/v. After gentle but thorough mixing treatment is carried out in an electroporator. The chamber of a Dialog ‘Porator’ (Dialog, Dusseldorf,
Germany) is sterilised by washing with 70% ethanol and then drying in sterile air.
Suspensions of protoplasts (~ ca 2 X 10° protoplasts/ml} in 0.4M mannito} + the DNA ) are adjusted with manganese chloride to a measured electrical resistance of ~ 1.4 k ohm.
Samples of volume ~ 0.4 ml are subjected, at 10 second intervals, to three pulses of applied voltages of between 1000 and 2000 V. The, thus transformed protoplasts are then collected ~ 10 and diluted back out into CC culture medium.
Those skilled in the art will recognise that many permutations and variations of these transformation procedures are possible and that, for example, transformation may also be improved by raising the pH to 9.5 and/or increasing the concentration of calcium ions in the solution within which transformation is carried out.
After 3-14 days aliquots of the developing cell cultures are transferred to medium containing alternative selecting concentrations of tissue-culture grade N-(phosphonomethy!) glycine (Sigma) between 1 and 5 mM (preferably 2 mM). Resistant cell colonies so identified (exhibiting growth on concentrations of glyphosate at least 2 fold greater than tolerated by untransformed controls) are transferred to fresh agar medium also containing a . range of selecting concentrations of glyphosate and, as described, in example 15, subcultured between plates containing successively declining concentrations of 2,4-D. Growing resistant : colonies May be analysed (by PCR etc) for the presence of the recombinant DNA. It may or may not be possible to effect much selection at the callus step. In any case all growing calli will be taken forward.
Growing calli are then transferred to shoot regeneration medium containing zeatin and N-(phosphonomethyl)glycine and thence to rooting medium exactly as described in example 15. Fertile transgenic plants expressing glyphosate-resistant EPSP synthase are then regenerated, selected and tested as known in the art and as described in example 15 and } using the analytical methods described in example 11.
N -43 -
EXAMPLE. 17. Method for assaying EPSPS activity and determination of kinetic constants. Method for assaying EPSPS activities in crude plant materials and discriminating the proportion of the total which is resistant to glyphosate.
EPSPS Enzyme assay
Assays are carried out generally according to the radiochemical method of Padgette et al 1987 (Archives of Biochemistry and Biophysics, 258(2) 564-573) with K+ ions as the major species of cationic counterion. Assays in a total volume of 50ul, in SOmM
Hepes(KOH) pH 7.0 at 25°C, contain purified enzyme or plant extract (see below) diluted appropriately in Hepes pH 7.0 containing 10% glycerol, and SmM DTT, '*C PEP either as variable substrate( for kinetic determinations) or fixed at 100 or 250 UM and shikimate 3
Phosphate (K+ salt) at 2 or 0.75 mM as indicated. Optionally, for assays of crude plant extracts, assays also contain 5 mM KF and/or 0.1 mM ammonium molybdate. Assays are started with the addition of *C phosphoenolpyruvate (cyclohexylammonium+ salt) and stopped after 2-10 minutes (2 minutes is preferable) with the addition of 50ul of a solution of 1 part IM acetic acid and 9 parts ethanol. After stopping, 20pl is loaded onto a synchropak
AX100 (25cm x 4.6mm ) column and chromatographed using isocratic elution with a 0.28M potassium phosphate pH 6.5 mobile phase flowing at 0.5 ml/min over 35 minutes.
Under these conditions the retention times for PEP and EPSP are ~ 19 and 25 minutes . respectively. A CP 525TR scintillation counter is connected to the end of the AX 100 column. Itis fitted with a 0.5ml flow cell, and the flow rate of scintillant ( Ultima Flo AP ) is . set at ml/min. Relative peak areas of PEP and EPSP are integrated to determine the percentage conversion of labelled PEP to EPSP. Apparent K,, and Vmax values are determined by least squares fit to a hyperbola with simple weighting using the Grafit 3.09b from Erithacus Software Ltd. Km values are generally ascertained using 8-9 concentrations of variable substrate ranging from K,, / 2 - 10 K,;, and triplicate points. Except where specifically noted, data points are only included in the analysis where there is < 30% conversion of substrate to EPSP.
Shikimate-3-Pi (S3P) is prepared as follows, To 7mls of 0.3M TAPS pH 8.5 containing 0.05M Shikimate, 0.0665M ATP ( Na salt), 10mM KF, 5mM DTT, and 0.05M
MgCl.6H0, 75ul of a 77 unit (pmol min” ) ml™' solution of shikimate kinase is added.
After 24hrs at room temperature, the reaction is stopped by brief heating to 95°C. The reaction solution is diluted 50 fold in 0.01M Tris HCI pH 9, and chromatographed by anion exchange on Dowex 1 X 8 - 400, using a 0 - 0.34M LiCl, gradient. The S3P fractions are combined, freeze dried, and then redissolved in 7mls distilled H-0. 28mls of 0.1M
Ba(CH3COOH); and 189mls of absolute ethanol are then added. This solution is left to stir overnight at 4°C. The resulting precipitate of tri-Barium S3P is collected and washed in 30mls of 67% ethanol. The washed precipitate is then dissolved in ~ 30mls distilled H-O. By adding either K,SO4 the K* or TMA" salt of S3P is produced as required. Great care is taken to add a minimal excess of sulphate. The BaSO, precipitate is removed and the supernatant containing the required salt of S3P freeze dried. Each salt is weighed and analysed by proton
NMR. S3P preparations so-prepared are > 90% pure according to proton NMR and (according to their weights and integration of 31P NMR) contain only low residues of potassium sulphate.
Preparation of extracts of plant material suitable for EPSPS assay
Callus or plantlet material (0.5 -1.0 g) is ground to a fine frozen powder in a liquid nitrogen-chilled mortar and pestle. This powder is taken up in an equal volume of a suitable chilled extraction buffer (for example, 50 mM Hepes/ KOH buffer at pH 7.5 containing 1 mM EDTA, 3 mM DTT, 1.7 mM ‘pefabloc’ (serine protease inhibitor), 1.5 mM leupeptin, 1.5 mM pepstatin A, 10% v/v glycerol and 1% polyvinylpyrolidone), resuspended, mixed and centrifuged in a chilled centrifuge to bring down debris. The supernatant is exchanged down a chilled PD10 column of Sephadex G25 into 25 mM Hepes/ KOH buffer at pH 7.5 ; containing I mM EDTA, 3 mM DTT and 10% v/v glycerol. Protein is estimated by the
Bradford method standardised using bovine serum albumen. A portion of the extract is frozen in liquid nitrogen; a portion is assayed immediately.
EPSPS assays of plant extracts are standardly carried out, as described above, with 0.1 mM "“C-PEP and 0.75 mM shikimate-3-Pi either in the absence or the presence of 0.1 mM N-(phosphonomethyl)glycine. Under these assay conditions, the resistant form of
EPSPS (see below) is estimated to be inhibited by < 8.5% whilst the sensitive w/t form is essentially fully inhibited (> 98%). Thus, the level of activity observed in the presence of glyphosate (A) is taken to represent ~ 92% of the level of resistant enzyme derived from expression of the transgene whilst the level of susceptible w/t EPSPS is taken to be the total level of EPSPS activity observed in the absence of glyphosate minus the value of A x ~ 1.08.
Because the Vmax of the mutant enzyme is estimated to be only about a third of the Vmax of the w/t enzyme (and because the Km values for PEP of both w/t and mutant forms are estimated to be about 20 uM or less), the level of expression of the mutant enzyme polypeptide relative to the level of expression of the endogenous w/t EPSPS is taken to be about three fold higher than the ratio calculated on the basis of the ratio of their relative observed activities. The total level of EPSPS polypeptide expression (mutant + wit) is also estimated by using Westerns (see below).
EXAMPLE. 18. Cloning and expression of w/t and mutated cDNA encoding mature rice EPSPS in E.coli. Purification and characterisation of w/t and mutant rice EPSPS
Expression, purification and characterisation of w/t mature rice EPSPS
Rice EPSPS cDNA is amplified using RT-PCR from RNA isolated from rice variety
Koshihikari using Superscript RT from BRL according to the recommendation supplied by the manufacturer. PCR is performed using Pfu turbo polymerase from Stratagene according to the methods supplied by the manufacturer. The oligonucleotides below are used in the amplification reaction and the reverse transcription steps.
SEQ. ID. NO. 23
Rice 3 0lig0 5’ GCGCTCGAGTCAGTTCCTGACGAAAGTGCTTAGAACGTCG 3°
SEQ. ID. NO. 24
Rice 5' oligo 5s’ GCGCATATGAAGGCGGAGGAGATCGTGC 3°
The PCR product is cloned into pCRBIlunt IT using Invitrogens Zero Blunt TOPO kit. The . sequence of the insert is confirmed by sequencing and it is verified that the predicted open reading frame corresponds to that of the predicted mature chloroplastic rice EPSPS protein } with the exception of the presence of an initiating Met. The cloned and verified rice epsps sequence is excised using Nde 1 and Xho 1 and the purified fragment is cloned into pET24a (Novagen) digested similarly. The recombinant clones are introduced into BL21 (DE3) a codon-optimised RP strain of E.coli supplied by Stratagene. The EPSPS protein is expressed in this strain following addition of 1 mM IPTG to the fermenter medium (LB supplemented with 100ug/ml Kanamycin). The recombinant protein of the correct predicted mass is identified 1) on the basis of Coomassie staining of SDS gels of cell extracts and side by side comparison with Coomassie-stained gels of extracts of similar E.coli cells transformed with an empty pET24a vector and ii) by western analysis using a polyclonal antibody raised to previously-purified plant EPSPS protein. The mature rice EPSPS protein is purified at ~ 4 C as follows. 25 g wet weight of cells are washed in 50 ml of 0.1M Hepes/ KOH buffer at pH 71.5 containing 5 mM DTT, 2 mM EDTA and 20% v/v glycerol. Following low-speed centrifugation, the cell pellet is resuspended in 50 ml of the same buffer but also containing 2 mM of ‘Pefabloc’ a serine protease inhibitor. Cells are evenly suspended using a glass - homogenizer and then disrupted at 10000 psi using a Constant Systems (Budbrooke Rd,
Warwick, U.K.) Basic Z cell disrupter. The crude extract is centrifuged at ~ 30,000 gforlh and the pellet discarded. Protamine sulphate (salmine) is added to a final concentration of 0.2% , mixed and the solution left to stand for 30 min. Precipitated material is removed by centrifugation for 30 min at ~ 30,000 g. Aristar grade ammonium sulfate is added to a final concentration of 40% of saturation, stirred for 30 min and then centrifuged at ~ 27,000 g for 30 min. The pellet is resuspended in ~ 10 ml of the same buffer as used for cell disruption, further ammonium sulfate is added to bring the solution to ~ 70% of saturation, the solution is stirred for 30 min and centrifuged again to yield a pellet which is resuspended in ~ 15 ml of S200 buffer (10 mM Hepes/ KOH (pH 7.8) containing 1 mM DTT, 1 mM EDTA and 20% v/v glycerol). This is filtered (0.45 micron) loaded and chromatographed down a K26/ 60 column containing Superdex 200 equilibrated with S200 buffer. EPSPS-containing fractions detected on the basis of EPSPS enzyme activity are combined and loaded onto an xk16 column containing 20 ml of HP Q-Sepharose equilibrated with S200 buffer. The column is washed with S200 buffer and then EPSPS eluted within a linear gradient developed from 0.0M to 0.2M KCl in the same buffer. EPSPS elutes within a single peak corresponding to a salt concentration at or below 0.1 M. EPSPS-containing fractions detected on the basis of
EPSPS enzyme activity are combined and loaded onto a HiLoad xk26/60 column of
Superdex 75 equilibrated with Superdex 75 buffer (25 mM Hepes/ KOH (pH 7.5) containing . 2 mM DTT, 1 mM EDTA and 10% v/v glycerol). EPSPS elutes later from the column that might be expected on the basis of the molecular weight of the presumed dimer. This may be due to interaction of the protein with the gel matrix at low ionic strength. EPSPS-containing fractions identified on the basis of enzyme activity are combined and loaded onto a ml © column of MonoQ equilibrated with the same, Superdex 75 buffer. The column is washed with starting buffer and EPSPS eluted as a single peak over the course of a 15 ml linear gradient developed between 0.0 and 0.2M KCl. EPSPS is obtained near (>90% pure) at this stage in the purification. Optionally, EPSPS is further purified by exchange into Superdex 75 buffer containing 1.0 M (Aristar) ammonium sulphate and loading onto a 10 ml column of phenyl sepharose equilibrated in the same buffer. EPSPS is eluted as a single peak early during the course of a linear gradient of declining ammonium sulphate developed between 1.0 and 0.0 M ammonium sulphate.
Cloning, expression, purification and characterisation of glyphosate-resistant mutant rice
EPSPS
The rice EPSPS cDNA in pCRBlunt is used as a template for two further PCR using the following primer pairs designed to introduce specific changes
SEQ ID NO 25 rice 5'0lig0 5’ GCGCATATGAAGGCGGAGGAGATCGTGC 3°
SEQ ID NO 26
Rice mutant reverse to RV 5" GCAGTCACGGCTGCTGTCAATGATCGCATTGCAATTCCAGCGTTCC 3°
SEQ ID NO 27
Rice 3' oligo 5’ GCGCTCGAGTCAGTTCCTGACGARAGTGCTTAGAACGTCG 3°
SEQ ID NO 28
Rice mutant forward to sal 5° GGAACGCTGGAATTGCAATGCGATCATTGACAGCAGCCGTGACTGC 3°
The resultant products are gel purified and placed into a tube in eqi-molar concentrations to serve as a template for another round of PCRs with the rice 5° and 3’ oligos. The resultant products are cloned into pCRBlunt II using Invitrogens Zero Blunt TOPO kit. It is confirmed that the DNA sequence of the insert and its predicted open reading frame correspond to that of the predicted mature chloroplastic rice EPSPS protein (with the exception of the presence of an initiating Met) and also that the desired changes (the specific mutation of T to Iand P to S at specific positions in the EPSPS sequence) are encoded . The thus cloned and verified rice epsps sequence is excised using Nde 1 and Xho 1 and the purified fragment cloned into pET24a (Novagen) digested similarly. The recombinant clones are introduced into BL21 (DE3), a codon optimised RP strain of E.coli supplied by Strategene. The EPSPS protein is expressed in this strain following addition of 1 mM IPTG to the fermenter medium (LB supplemented with 100ug/ml Kanamycin). The recombinant protein of the correct predicted mass is identified 1) on the basis of Coomassie staining of SDS gels of cell extracts and side by side comparison with Coomassie-stained gels of extracts of similar E.coli cells transformed with an empty pET24a vector and ii) by western analysis using a polyclonal antibody raised to previously-purified plant EPSPS protein. This mutant form of rice EPSPS is purified and characterised in a similar manner to the method described above for w/t rice
EPSPS.
The so-obtained mutant form of rice EPSPS, assayed as described above in the presence of 2 mM shikimate-3-Pi, has an apparent Vmax of ~ 10 pmol/ min/ mg and a Km for PEP of 22 uM. At 40 uM PEP, the IC50 value for the potassium salt of glyphosate is ~ 0.6 mM. The estimated Ki value for potassium glyphosate of the mutant EPSPS is ~ 0.2 mM.
EXAMPLE. 19. Preparation of antibodies to purified rice EPSPS and methods for
Western analysis . 10 Standard methods for generation of polyclonal antisera in rabbits are used. Rabbits are young female New Zealand Whites. Immunisation courses consist of 4 doses, each ~ 100 mg, administered at monthly intervals. Each dose in phosphate buffered saline is administered as an emulsion with Freund's Complete adjuvant (dose 1) or Incomplete adjuvant (doses 2-4) and is injected at four sub-cutaneous sites. A pre-bleed is taken before dose | is administered. A test bleed is taken 14 days after the second dose to confirm the immune response. A term bleed is taken 14 days after the fourth dose and used for experimentation. A fifth and final dose is given when at least 6 weeks has elapsed since the fourth dose, and the final bleed (also used for experimentation) is taken 14 days later.
Antibodies are raised to both (i) purified native mature w/t rice EPSPS (example 8) - and also (ii) to SDS-denatured rice EPSPS polypeptide which is eluted from a band cut out of a 12% SDS gel (the correct position of the protein being accurately marked by side by side :
Coomassie staining of the band). 12% polyacrylamide gels are used for SDS gel electrophoresis and Western blotting.
Electrophoresis is performed at a constant current of 100V for 90 minutes. Gels are blotted against nitrocellulose sheets overnight at 4 C at a constant 30V. Sheets are blocked in 5%
Marvel phosphate buffered saline containing 0.1% Tween (PBS-tween) for 1 or 2 hours, washed three times in PBS-tween and incubated in rice EPSPS-Rb1 primary antibody at ~ 1.3 mg IgG/ml (normally equivalent to a 1:4000 to 1: 20,000 dilution of term bleed). These . antibody dilutions are applied in PBS (phosphate-buffered saline) containing 1% Marvel and 0.05% Tween 20 for 2 hours. Secondary antibody, Goat anti Rabbit HRP (Sigma A6154) is applied at 1:10,000 or 1:20,000 in PBS containing 0.05% Tween and 1% Marvel. Incubation with secondary antibody is continued for 1 hour, the blott is washed three times in PBS
¢ -49 - (0.05% tween), ECL substrate is applied for usually 1 minute and film exposed for 10-60 seconds. Negative control blots are blots with (1) preimmune serum at a dilution calculated to yield the same [IgG] as in test immune sera (IgG is routinely purified from an aliquot of each serum and quantitated so that these dilutions can be calculated directly) and also (2) immune serum raised against Freund's adjuvant alone. IgG concentration in control immune sera is adjusted so that controls are at an appropriate concentration of IgG. In order to make this calculation, IgG is purified from crude antiserum by filtration through a 0.45um syringe filter and passed down a 1ml HiTrap protein G column (Pharmacia cat no:17-0404-01). The bound IgG is eluted from the column with 0.1M glycine HCI pH 2.9 and dialysed vs PBS overnight. The IgG concentration is estimated by UV determination. (a 1 cm pathlength of a 1 mg ml" solution of pure IgG has an absorbance at 280nm wavelength of 1.35). From the
IgG yield a calculation can be made of IgG concentration in the crude antiserum, and correct dilutions in western blots calculated accordingly.
Plant tissue samples are prepared for example as described in example 17.
Alternatively, for Western analysis, a much simpler procedure is used. 100-200 mg of plant tissue to be analysed is rapidly homogenized (for example using an ultra turrax, bead beater or glass homogenizer) in an equal volume of buffer (similar to in example 7), centrifuged for 5 minutes in a chilled eppendorf microcentrifuge and the supernatant a) a small aliquot is ) analysed for protein using the Bradford method and b) for the most part mixed 1:1 with Laemli SDS ‘sample buffer’, heated and then stored ready for loading onto gels. Typically } SDS slab gels are loaded with 10 protein samples in 10 wells. Typically these are 1 to 10 pg of crude extracts of plant material for analysis alongside a standard curve of between 0 and 20 ng of pure rice EPSPS. In some cases Westerns are run using antibodies raised to purified w/t EPSPS from Brassica napus (expressed and purified using similar methods to those described above). In this case the strength of the cross reaction of the antibodies is less strong with rice EPSPS (or with endogenous plant wheat or maize EPSPS) than in the case that antibodies raised to rice EPSPS be used but still, nevertheless, provide sufficient reaction for useful quantitative information in relation to the standard curve to be derivable.
EXAMPLE 20. Isolation of genomic DNA from transgenic plant material. PCR analysis. DNA probe preparation and hybridisation. Copy number and integrity of o transgene.
Genomic DNA is isolated from plants, plantlets and callus material using ,for example, the method of Dellporta et al (1983) in Chromosome Structure and Function:
Impact of New Concepts, 18’th Stadler Genetics Symposium. J.P. Gustafson and R . Appels, eds). New York: Plenum Press) pp 263-282 or, alternatively, the DNAeasy kit (Qiagen) may be used. Transgenic callus and plant segregants that contain the mutated rice EPSPS transgene are identified using fluoresence PCR using oligonucleotide primers SEQ ID NO. 39 and 40 that are specific to the mutations within the rice EPSPS genomic sequence. The : fluorescent dye SYBR green which intercalates with double stranded DNA, is included in the
PCR so that samples containing the mutated rice EPSPS gene are detected by an increase in fluorescence in the sample which is detected using an ABI 3377 machine. Alternatively those skilled in the art will know that the primers may be fluorescently labelled and technologies such as molecular beacons and ‘Scorpions’ are available.
SEQ. ID. NO. 29
RiceDM Fwd2-3A 5’ -gtg gaa cgc tgg aat tgec aat gca at -3°
SEQ. ID. NO. 30
Univeral Reverse 5’~ gtt gca ttt cca cca gca gca gt - 3! .
A typical PCR consist of , prepared in 96 well optical plates and sealed with Optical lids (PE Biosystems), is as follows in 25 pl total volume: . 5.0 pl gDNA template (Qiagen Dneasy prep) 12.5 ul 2X SYBR Green premix 2.5 pl Spmol/ul stock forward primer 2.5 pl Spmol/ pl stock reverse primer 2.5uldd H20
The following cycling parameters are followed:
Stage 1: 50 C for 2 min
Stage 2: 95 C for 10 min
Stage 3: 95Cfor 15s 60 C for 45 s
Changes in fluorescence within the samples are recorded every seven seconds from stage 3 of the reaction
For Southern blotting approximately 10 pg of DNA is used for each restriction digest.
Genomic DNA is digested with suitable restriction enzymes (e.g Hind III) according to the manufacturer’s instructions (e.g Promega). Restriction enzymes are chosen that cut both within and outside the mutant EPSPS sequence. DNA is separated using TAE (0.04M tris- acetate, 1 mM EDTA) 0.8% agarose gels. Southern blotting is carried out according to methods giving by Sambrook et al., 1989 using HyBond N+ nitrocellulose blotting membrane (AmershamPharmacia). The DNA is cross-linked to the membrane by exposure to UV illumination.
DNA fragments used for generating specific probes are isolated by purification on gels of restriction digests of plasmid DNA or generated by PCR. For example, a 700 bp fragment containing intron 1 of the rice EPSPS gene, is generated by PCR using primers as shown below.
SEQ.ID.NO 31
INT1/55’ cccttcctettgegtgaattecattte 3°
SEQ. ID. NO. 32
INT1/35’ gttgtgccectaataaccagag 3° . Such probes are labelled with **P using the random priming method, for example Ready-To-Go DNA labelling beads (AmershamPharmacia) and purified using, for example, ) MicroSpin G-25 columns (AmershamPharmacia).
Blots of DNA gels are prehybridized at 65 C in Sx SSC, 0.5% SDS, 2xDenhardt’s solution, 0.15 mg/ m! denatured salmon sperm DNA for at least one hour. The blot is then hybridized with denatured probe for 16-24 h at 65 C in fresh pre-hybridisation solution.
Membranes are blotted dry and visualised using autoradiography.
Where Southern blotting indicates a single integration event of the transgene at a single locus, indicted by the probe hybridising with only a single specific sized restriction fragment, then the result is confirmed through a rehyridisation of the blot using an alternative probe. For controls, untransformed material is used. Additionally the blot may be probed further with hybridisation probes specific to other regions of the transgenic construct (for example the promoter, 5’UTR intron or upstream enhancer sequences) in order to verify the integrity of the construct. Additionally, in the case that Agrobacterium transformation is used, specific probes are used to indicate the presence or absence of any DNA extending from beyond the RB and LB of the super-binary vector.
SEQ ID NO. 33 Rice EPSPS genomic (from ATG - WT sequence) atggcggcgaccatggcgtccaacgecgeggetgeggecggeggtgtccctggaccaggecgtggeggegteggeggegttcte gtcgeggaagcagetgeggetgoeccgeecgeggegegeggggggatgegggtgegggtgegggegekggggeggegggadycgy tggtggtggegtecgegtegtcgtecgtcggtggecagegecggeggcgaaggeggaggagatecgtgetccageccatcagggag atctccggggeggttcagectgccagggteccaagtecgetetccaacaggatectectectctecgecctctcecgaggtgagacg cggatcccttcetcttgegtgaattcecatttectggagatgagattttagggggtttattaggtgaggtggetgtgtttgtgaa atcctaggaattatctctcaagtcaatctaacgatgagatataactgaggttctggttttaatcacacactcatataaccaat ttattgaaacattttggtttggcataagaaactgcttacgaaggtatgatatcctectacatgtcaggctactaaattttcac gacggtatgatccactcaaaacaagtttcttaacgagtctggtgaggtctgttatgaaatttgtgtaaactaaggcaactttg gaggtttcgcactgtaccaatgttatgtttgaacattttgcaagcagtgctttctcccaaaattatgecaattttgaggctect ctacatcattataattccccaatacattgetctttattcttaatagectttgatcgegaaatttaacattttaattettgaget gttattttgtagcatcagtttatcatgagccatgtttggtactaaatatacaateccttgggtttatttgtttccaagecatgt cattaacttatcttaatgtggacaagaaactgatgcctgcttacattgctattatttcaagecgggtattgatectttgacatg tgattgatcatttttttttetctggttattagggcacaacagtggtggacaacttgctgaacagtgaggatgttcactacatg cttgaggccctgaaagccctcocgggctetectgtggaagcagataaagttgcaaaaagagctgtagtegttggetgtggtggecaa gtttcctgttgagaaggatgcgaaagaggaagtgcaactcttcttggggaacgetggaactgcaatgecgaccattgacagecag ccgtgactgctgectggtggaaatgcaacgtatgtttttttttttaatgtttatgaaaatatgtatggaattcatggggtatgt tttatgacctttttctttaccatcagttatgtgcttgatggagtgccacgaatgagggagagaccgattggtgacttggttgt cgggttgaaacaacttggtgcggatgtcgactgtttccttggcactgaatgecccacctgttegtgtcaagggaattggaggac ttcectggtggecaaggttagttactecctaaactgecatcoctttgtacttectgtatgecacctecaattetttgtcaaccttetgeat ttataaggaacattctatgatgcaattcgaccttacactgcacagtaacttgaaatgtttcatgettaatcaatatgecatat tcctgccaagectcaagecgagcaatatttgtttgaatttggtaccatatttttgtatatttgggecattcectttttggtettgat gtcttcttttgaattagcatttaactgaattacactcaacaggttaagctctctaggttccatcagcagtcagtacttgagtge cttgctgatggctgctectttggeccettggggatgtggagatcgaaatcattgacaaactaatctceccattecttacgttgaaa tgacattgagattgatggagcgttttggtgtgaaggcagagcattetgatagttgggacagattctatattaagggagggcag aagtacaagtaagcttctacctgecttactgagctgaattattcgggtgtttatgattaactcectaaactaacecctttttet tttctttggcattgacagatctcctggaaatgectatgttgaaggtgatgectcaagegecgagctatttecttggetggtgetg caatcactggaggcactgtgacagttcaaggttgtggtacgaccagtttgcaggtataactgtagtgectgttttgacattct accgtttagtcaagtttagtcagtagtcacatattcagaatatagcacaatctgtattatgccactgttaatcaaatacgcett gacctagagagtgctatataccctagcttaatcttcaaactaaacagttctecttgtggettgetgtgetgttatgttecctga ’ cctacatgttaatattacagggtgatgtcaaatttgctgaggtacttgagatgatgggagcaaaggttacatggactgacacce agtgtaaccgtaactggtccaccacgtgagccttatgggaagaaacacctgaaagectgttgatgtcaacatgaacaaaatgec tgatgttgccatgaccecttgecgttgttgcactcttegetgatggtecaactgectatcagagatggtaaacattaaggectat tatacctgttctatcatactagcaattactgcttagcattgtgacaaaacaaataaccaaactttcttcaaaataacttagaa atataagaaaggttcgttttgtgtggtaaacagtactactgtagtttcagctatgaagtttgetgctggeaattttetgaacy gtttcagctaaattgcatgtttgttcatcatacttatccattgtcttccacagtggecttecctggagagtaaaggaaaccgaaa ggatggttgcaattcggaccgagctaacaaaggtaaattcattaggtccegtgtectttcattcttcaagtagtttgttecata agttgaattctccttcaatgatgtttaaattcatcatcttcttttttggtgttgtgccagetgggagcateggttgaagaagg tccotgactactgcatcatcaccccaccggagaagctgaacatcacggeaatcgacacctacgatgatcacaggatggcecatgg 40 ccttctecctegetgectgegecgacgtgeccgtgacgatcagggaccctggttgcacccgcaagaccttecccaactactte gacgttctaagcactttcgtcaggaactgaactgagcttttaaaagagtgaggtctaggttctgttgtctgtetgtecatcat ccatgtgttgactgttgagggaactcgtttcttettttcttcacgagatgagtttttgtgtgectgtaatactagtttgtage aaaggctgcgttacataaggtgatgagaattgaggtaaaatgagatctgtacactaaattcattcagactgttttggcataaa gaataatttggccttctgecgatttcagaagctataaattgecatctecactaaattctecttggtectcatggcaatgecaacga 45 cagtgtgaagcactgaagcccgtaatgctctatcaccaccatgtacgacagaaccatatatgtccatatgtacaactcgagtg ttgtttgagtggccagcaaactggctgaccaagccacacgagagagaatactataaactcaatcatacataacaageccaage aacattagacagaacacaacaacactcg
.
SEQ ID NO. 34 Rice EPSPS genomic (from ATG including double mutant - shown) atggcggcgaccatggegtccaacgcegeggetgeggeggeggtgtecectggaccaggecgtggeggegteggeggegt tet e gtcgcggaagcagcetgeggetgeccgeegeggegegeggggggatgegggtgegggt gegggegekyggggeggegggaggegg . tggtggtggegtccgegtegtegtegteggtggcagegecggeggcgaaggeggaggagatcgtgetecageccatcagggag atctccggggeggttcagetgecagggtecaagtegetctccaacaggatectectectetecgeectetecgaggtgagacy cggatcccttectottgegtgaattccatttetggagatgagattttagggggtttattaggtgaggtggetgtgtttgtgaa atcctaggaattatctctcaagtcaatctaacgatgagatataactgaggttctggttttaatcacacacteatataaceaat ttattgaaacattttggtttggcataagaaactgcttacgaaggtatgatatcctectacatgtcaggctactaaattttcac gacggtatgatccactcaaaacaagtttcttaacgagtctggtgaggtctgttatgaaatttgtgtaaactaaggcaactttg gaggtttcgcactgtaccaatgttatgtttgaacattttgeaagecagtgctttcteccaaaattatgecaattttgaggctect
Cctacatcattataattccccaatacattgetctttattcttaatagetttgatcgegaaatttaacattttaattettgaget grtattttgtagcatcagtttatcatgagecatgtttggtactaaatatacaatcecttgggtttatttgtttccaageatgt cattaacttatcttaatgtggacaagaaactgatgcctgettacattgctattatttcaagegggtattgatcctttgacatg tgattgatcattretttttctctggttattagggcacaacagtggtggacaacttgctgaacagtgaggatgttcactacatg cttgaggccctgaaagccctegggctetetgtggaagcagataaagttgcaaaaagagetgtagtegttggetgtggtggeaa gtttectgttgagaaggatgcgaaagaggaagtgcaactcttettggggaacgctggaaTtgcaatgegaTcattgacagcag ccgtgactgctgctggtggaaatgcaacgtatgtttttttttttaatgtttatgaaaatatgtatggaattcatggggtatgt tttatgacctttttctttaccatcagttatgtgcttgatggagtgccacgaatgagggagagaccgattggtgacttggttgt cgggttgaaacaacttggtgeggatgtegactgtitecttggcactgaatgecccacctgttegtgtcaagggaattggaggac ttectggtggcaaggttagttactcctaaactgcatcetttgtacttctgtatgcacctcaattectttgtcaaccttetgeat ttataaggaacattctatgatgcaattcgaccttacactgecacagtaacttgaaatgtttcatgcttaatcaatatgecatat tcctgccaagectcaagecgagcaatatttgtttgaatttggtaccatatttttgtatatttgggcatteetttttggtettgat } gtcttcttttgaattagcatttaactgaattacactcaacaggttaagectctctggttccatcagcagtcagtacttgagtge cttgctgatggctgctectttggeccttggggatgtggagatcgaaatcattgacaaactaatcteccatteccttacgttgaaa tgacattgagattgatggagcgttttggtgtgaaggcagagcattcetgatagttgggacagattctatattaagggagggcag ' aagtacaagtaagcttctacctgcecttactgagctgaattattcgggtgtttatgattaactccctaaactaaccetttttet tttctttggcattgacagatctcctggaaatgectatgttgaaggtgatgectcaagegegagetatttettggetggtgetyg ] caatcactggaggcactgtgacagttcaaggttgtggtacgaccagtttgcaggtataactgtagtgectgttttgacattct accgtttagtcaagtttagtcagtagtcacatattcagaatatagcacaatctgtattatgccactgttaatcaaatacgctt gacctagagagtgctatataccctagcttaatcttcaaactaaacagttctcttgtggettgetgtgetgttatgttecectga ) cctacatgttaatattacagggtgatgtcaaatttgctgaggtacttgagatgatgggagcaaaggttacatggactgacace agtgtaaccgtaactggtccaccacgtgagecttatgggaagaaacacctgaaagctgttgatgtcaacatgaacaaaatgee tgatgttgccatgacccttgcecgttgttgcactcttecgetgatggtccaactgctatcagagatggtaaacattaaggectat tatacctgttctatcatactagcaattactgcttagcattgtgacaaaacaaataaccaaactttcttcaaaataacttagaa atataagaaaggttcgttttgtgtggtaaacagtactactgtagtttcagctatgaagtttgctgetggeaattttctgaacg gtttcagctaaattgcatgtttgttcatcatacttatccattgtcttccacagtggcttcctggagagtaaaggaaaccgaaa ggatggttgcaattcggaccgagctaacaaaggtaaattcattaggtccegtgtectttcattcttcaagtagtttgttcata agttgaattctccttcaatgatgtttaaattcatcatcttettttttggtgttgtgeccagetgggagecatecggttgaagaagg tcctgactactgcatcatcaccccaccggagaagctgaacatcacggcaatcgacacctacgatgatcacaggatggecatgg 40 ccttctecctegetgectgegecgacgtgeccgtgacgatcagggaccctggttgcaccegcaagaccttceccaactactte gacgttctaagcactttcgtcaggaactgaactgagettttaaaagagtgaggtctaggttctgttgtetgtctgtecatcat : ccatgtgttgactgttgagggaactcgtttcttecttttecttcacgagatgagtttttgtgtgectgtaatactagttrtgtage aaaggctgcgttacataaggtgatgagaattgaggtaaaatgagatctgtacactaaatteat teagactgttttggeataaa gaataatttggccttectgcgatttcagaagctataaattgeccatctcactaaattectcocttggtcectcatggecaatgcaacga 45 cagtgtgaagcactgaagcccgtaatgctctatcaccaccatgtacgacagaaccatatatgtccatatgtacaactegagtg ttgtttgagtggccagcaaactggctgaccaagccacacgagagagaatactataaactcaatcatacataacaagcccaage aacattagacagaacacaacaacactcg
N
SEQ ID NO. 35 Rice GOS2 Enhancer gaatccgaaaagtttctgecaccgttttcacgttctaactaacaatatagggaacgtgtgctaaatataaaatgagaccttata tatgtagcgctgataactagaactatgtaagaaaaactcatccacctactttagtggcaatcgggetaaataaaaaagagtcg
Ctacactagtttcgttttecttagtaattaagtgggaaaatgaaatcattattgcttagaatatacgttcacatctctgteat gaagttaaattattcgaggtagccataattgtcatcaaactcttcttgaataaaaaaatctttctagctgaactcaatgggta aagagagatattttttttaaaaaaatagaatgaagatattctgaacgtatcggcaaagatttaaacatataattatataattt tatagtttgtgcattcgttatatcgcacgtcattaaggacatgtcttactccatctcaatttttatttagtaattaaagacaa ttgacttatttttattatttatcttttttegattagatgcaaggtacttacgcacacactttgtgctcatgtgecatgtgtgag tgcacctcctcaatacacgttcaactagcgacacatctctaatatcactcgectatttaatacatttaggtagcaatatetga attcaagcactccaccatcaccagaccacttttaataatatctaaaatacaaaaaataattttacagaatagcatgaaaagta tgaaacgaactatttaggtttttcacatacaaaaaaaaaaagaattttgctcgtgecgecgagegecaatcteccatattgggea cacaggcaacaacagagtggctgecccacagaacaacccacaaaaaacgatgatctaacggaggacagce
SEQ ID NO. 36 Barley Plastocyanin Enhancer
Ccaaaatctcccatgaggagcacctcaatgeccctcgggtgeecgtgtagatttccacccgacacatatttgttactectteegt cacagtttataaggcatgcacgtatacctaggtcgtcaatttgaccaacttaatgagagacatatattacaaaaaatatatca ttaaaaacttttagatgtactattttgtaatgatataatttttatgttaaacaatatatttnatttaagttaagttgacgacc taggtacacgtgtacgccttatnaactgtgacggagggagtattgtagttatgaataactttttetatacacttttttgtggg ggaactttttctataaacttgaccacgataataactgcaatttttatctaaaacaatacttatgttgttccttgtcacggtaa gatacgtaccatggttaatgatggaggtagtttcaaaataaatatctcaagtttaatacacatttatatactagagttaatac aaagttaagacaattatgttgaaacggaagaagtatatatatacaaagttaatagaatgagttggtacatacactatataaat agtggagcgtggaggcgatcgagtgaatgtatacgttgcagcecgtggagaagacgaggaggggatcatgtgtttgtggaccat atatattatgatgaggacatgcatgtggagatatatatatatggatgggatgatattgggctacctcacctcatccggatgga gaggcgg } SEQ ID NO. 37 Rice Genomic G1 EPSPS (to ATG) gttggttggtgagagtgagacaccgacggaacggaaggagaaccacgccgcttggatttttettttttaccttttecaaatttt aatttaaaaaataaaaccattttaaaaacttatcttcaaatacaaatcttttaaaaacactaacacgtgacacacagcgggca
A cgtcacccaaacgggcdgtgacaatattgttttgeccacaccaatccagctggtgtggacaaaatgttcatatattgaaaataaa atttaaaacaatttatattttttatctatatcattataaaaattgaagatgtttttaccggtattttgttactcatttgtgea tgagtcggtttttaagtttgttcgettttggaaatacatatccgtatttgagtatgtttttaagttcgttegttttttgaaat acaaaaggaatcgtaaaataaatctattttaaaaaactcgcatgctaacttgagacgatcgaactgctaattgecagetcataa ttttccaaaaaaaaatatatccaaacgagttcttatagtagatttcaccttaattaaaacatataaatgttcacceggtacaa cgcacgagtatttttataagtaaaattaaaagtttaaaataaataaaaatccegecaccacggegegatggtaaaagggggac gcttcetaaacgggecgggcacgggacgatcggccccgaacceggececatctaaccgetgtaggeccacegeccaccaatccaa ctccgtactacgtgaagcgctggatcecgcaaccegttaagecagtecacacgactegactegactegegeactegeecgtggtag gtggcaacccttecttectectctatttcttettettecteccttectecgect caccacaccaaccgcaccaaccccaacceeg cgcgegcetcectecccctctececteccaccaaceccacccecatectecegacctccacgecgecggcaatg 40 SEQ ID NO. 38 Rice Genomic G3 EPSPS (to ATG) ttaattaaaacatataaatgttcacccggtacaacgcacgagtatttttataagtaaaattaaaagtttaaaataaataaaaa tccegecaccacggegcgatggtaaaagggggacgettctaaacgggecgggcacgggacgatcggececgaacceggeceat ctaaccgetgtaggeccaccgeccaccaatccaactcegtactacgtgaagegetggatccgcaacccgttaagcagtccaca cgactcgactcgactcgcegeactcgecgtggtaggtggcaaccettcttectectetatttettettettectecctteteeg
~
Cctcaccacaccaaccgcaccaaccccaaccecgegegegetetecectetececteccaccaaccccaccceatecteecga cCtccacgccgceggcaatg
SEQ ID NO. 39 Rice Genomic G2 EPSPS +Maize Adhl intron gccacaccaatccagctggtgtggacaaaatgttcatatattgaaaataaaatttaaaacaatttatattttttatectatatce attataaaaattgaagatgtttttaccggtattttgttactcatttgtgcatgagteggtttttaagtttgttegettttgga aatacatatccgtatttgagtatgtttttaagttegttegttttttgaaatacaaaaggaatcgtaaaataaatcetattttaa aaaactcgcatgctaacttgagacgatcgaactgctaattgcagctcataattttccaaaaaaaaatatatccaaacgagttc ttatagtagatttcaccttaattaaaacatataaatgttcacccggtacaacgcacgagtatttttataagtaaaattaaaag tttaaaataaataaaaatcccgccaccacggcgegatggtaaaagggggacgcttctaaacgggecgggcacgggacgatogg ccccgaacccggeccatctaaccgetgtaggeccaccgeccaccaatecaactecgtactacgtgaagegetggateaegeaac ccgttaagcagtccacacgactcgactcgactcgegcactcgcecgtggtaggtggcaaceettettectectctatttettct tctteoctcecttetecgectcaccacaccaaccgcaccaaccccaacceecgegegegectecteccctetececcteccaccaace ccaccccatccteecgacctecacgecgecggcaggatcaagtgcaaaggtecgecttgtttetectetgtetottgatctga
Ctaatcttggtttatgattcgttgagtaattttggggaaagctagecttegtecacagtttttttitegatgaacagtgecgea gtggcgctgatcttgtatgetatectgeaategtggtgaacttatttettttatatecttcacteccatgaaaaggctagtaa tctttectcgatgtaacatcgtccagcactgetattaccgtgtggtccatocgacagtectggectgaacacatcatacgatattg agcaaagatctatcctccctgttctttaatgaaagacgtcattttcatcagtatgatctaagaatgttgcaacttgcaaggag gegtttctttctttgaatttaactaactcecgttgagtggeectgtttetecggacgtaaggectttgetgetecacacatgteca ttcgaattttaccgtgtttagcaagagcgaaaagtttgcatcttgatgatttagettgactatgegattgetttecctggacee gtgcagctgcggatg
SEQ ID NO. 40 Maize Adhl intron gtcegecttgtttctectectgtectecttgatctgactaatcttggtttatgattegttgagtaattttggggaaagectagette gtccacagtttttttttcgatgaacagtgeccgecagtggegetgatettgtatgctatcctgcaategtggtgaacttatttet tttatatccttcactceccatgaaaaggctagtaatctttctegatgtaacategteccageactgectattaccgtgtggtecat . ccgacagtctggctgaacacatcatacgatattgagcaaagatctatectecctgttectttaatgaaagacgtecattttcate agtatgatctaagaatgttgcaacttgcaaggaggegtttectttctttgaatttaactaactecgttgagtggcecctgtttete ggacgtaaggcctttgctgctccacacatgtceccattcgaattttaccgtgtttagcaagagcgaaaagtttgecatcttgatga - tttagcttgactatgegattgetttectggaccegtgecag
Claims (52)
1. An isolated polynucleotide comprising the sequence depicted in SEQ ID No. 33.
2 A polynucleotide encoding an EPSPS, excluding the cDNA encoding the rice and corn EPSPS, which polynucleotide is complementary to one which when incubated at a temperature of between 65 and 70°C in 0.1 strength citrate buffered saline containing 0.1% SDS followed by rinsing at the same temperature with 0.1 strength citrate buffered saline containing 0.1% SDS still hybridises with the sequence depicted in SEQ ID No. 33.
3. A polynucleotide encoding an EPSPS, other than the maize EPSPS, obtainable by screening plant genomic DNA libraries with a polynucleotide constituting an intron within the SEQ ID No. 33 sequence.
4. An isolated polynucleotide comprising a region encoding a chloroplast transit peptide
. and a glyphosate resistant 5-enolpyruvylshikimate phosphate synthase (EPSPS) 3' of the peptide, the said region being under expression control of a plant operable ) oT promoter, with the provisos that the said promoter is not heterologous with respect to the said region, and the chloroplast transit peptide is not heterologous with respect to the said synthase. .
5. A: polynucleotide according to any one of claims 1 to 4, comprising the following components in the 5' to 3' direction of transcription:- ® At least one transcriptional enhancer being that enhancing region which is upstream from the transcriptional start of the sequence from which the enhancer is obtained and which enhancer per se does not function as a promoter either in the sequence in which it is endogenously comprised or when present heterologously as part of a construct; : (ii) The promoter from the rice EPSPS gene; (iii) The rice genomic sequence which encodes the rice EPSPS chloroplast transit peptide; : AMENDED SHEET
(iv) The genomic sequence which encodes the rice EPSPS; (v) A transcriptional terminator; wherein the rice EPSPS coding sequence is modified in that a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which comprise the following conserved region GNAGTAMRPLTAAY in the wild type enzyme such that modified sequence reads GNAGIAMRSLTAAV.
6. A polynucleotide according to claim 5, wherein the said enhancer comprises a sequence the 3” end of which is at least 40 nucleotides upstream of the closest transcriptional start of the sequence from which the enhancer is obtained.
7. A polynucleotide according to either of claim 5 or 6, wherein the enhancer comprises a region the 3" end of which is at least 60 nucleotides upstream of the said closest start.
8. A polynucleotide according to claim 5, wherein the said enhancer comprises a sequence the 3” end of which is at least 10 nucleotides upstream from the first . nucleotide of the TATA consensus of the sequence from which the enhancer is obtained. .
9. A polynucleotide according to any one of claims 1-8, comprising first and second transcriptional enhancers.
10. A polynucleotide according to claim 9, wherein the first and second enhancers are tandemly present in the polynucleotide.
11. A polynucleotide according to any one of claims 5-10, wherein the 3’ end of the enhancer, or first enhancer, is between about 100 to about 1000 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
12. A polynucleotide according to any one of claims 5-11, wherein the 3’ end of the enhancer, or first enhancer, is between about 150 to about 1000 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
13. A polynucleotide according to any one of claims 5-12, wherein the 3’ end of the enhancer, or first enhancer, is between about 300 to about 950 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
14. A polynucleotide according to any one of claims 5-15, wherein the 3’ end of the enhancer, or first enhancer, is between about 770 and about 790 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
15. A polynucleotide according to any one of claims 5-13, wherein the 3’ end of the enhancer, or first enhancer, is between about 300 and about 380 nucleotides upstream . of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
16. A polynucleotide according to any one of claims 5-13 and 15, wherein the 3” end of the enhancer, or first enhancer, is between about 320 and about 350 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
17. A polynucleotide according to any one of claims 5-16, wherein the region upstream of the promoter from the rice EPSPS gene comprises at least one enhancer derived from a sequence which is upstream from the transcriptional start of either the barley plastocyanin or GOS2 promoters.
18. A polynucleotide according to claim 17, comprising in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of either the barley plastocyanin promoter and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the GOS 2 promoter.
19. A polynucleotide according to claim 17, comprising in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the GOS 2 promoter and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the barley plastocyanin promoter.
20. A polynucleotide according to any one of claims 4-19, wherein the nucleotides S' of - the codon which constitutes the translational start of the rice EPSPS chloroplast transit peptide are Kozak preferred.
21. A polynucleotide according to any one of claims 4-20, wherein 5' of the rice genomic sequence which encodes the rice EPSPS chloroplast transit peptide there is located a . non-translated region which comprises a sequence which functions as an intron.
22. A polynucleotide according to claim 21, wherein the non-translated region comprises an intron, wherein the intron is the maize ADHI intron.
23. A polynucleotide according to either of claims 21 or 22 wherein the non-translated region comprises the sequence depicted in SEQ ID NO. 40.
24. A polynucleotide according to any one of claims 4-23, which comprises a virally } derived translational enhancer or other non-viral translational enhancer located within the non translated region 5' of the rice genomic sequence which encodes the rice EPSPS chloroplast transit peptide.
25. A polynucleotide according to any one of claims 4-24, further comprising regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, dessication, and herbicides.
26. A polynucleotide according to claim 25, wherein the herbicide is other than glyphosate.
27. A polynucleotide according to either of claims 25 or 26, wherein the insect resistance conferring regions encode crystal toxins derived from Bt, including secreted Bt toxins; protease inhibitors, lectins, Xenhorabdus/Photorhabdus toxins; the fungus resistance conferring regions are selected from the group consisting of those encoding known AFPs, defensins, chitinases, glucanases, Avr-Cf9; the bacterial resistance conferring regions are selected from the group consisting of those encoding cecropins and techyplesin and analogues thereof; the virus resistance regions are selected from the group consisting of genes encoding virus coat proteins, movement proteins, viral replicases, and antisense and ribozyme sequences which are known to provide for virus resistance; the stress, salt, and drought resistance conferring regions are selected
. from those that encode Glutathione-S-transferase and peroxidase, the sequence which constitutes the known CBF1 regulatory sequence and genes which are known to } provide for accumulation of trehalose.
28. A polynucleotide according to claim 27, wherein the insect resistance conferring regions are selected from the group consisting of cryIAc, crylAb, cry3A, Vip 1A,Vip 1B, cystein protease inhibitor, and snowdrop lectin genes.
29. A polynucleotide according to any preceding claim, which is modified in that mRNA instability motifs and/or unwanted splice regions are removed, or crop preferred codons are used so that expression of the thus modified polynucleotide in a plant yields substantially similar protein having a substantially similar activity/function to that obtained by expression of the protein encoding regions of the unmodified polynucleotide in the organism in which they are endogenous.
30. A polynucleotide according to the preceding claim, wherein the degree of identity between the modified polynucleotide and a polynucleotide endogenously contained within the said plant and encoding substantially the same protein is such as to prevent co-suppression between the modified and endogenous sequences.
31. A polynucleotide according to the preceding claim, wherein the said degree is less than about 70%.
32. A vector comprising the polynucleotide of any preceding claim.
33. Plant material which has been transformed with the polynucleotide of any one of claims 1-31, or the vector of claim 32.
34. Plant material which has been transformed with the polynucleotide of any one of claims 1-31 or the vector of claim 32, and which has been, or is, further transformed with a polynucleotide comprising regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, desiccation, . and herbicides.
35. Morphologically normal, fertile whole plants which have been regenerated from the material according to either of claims 33 or 34, their progeny seeds and parts.
36. Morphologically normal fertile whole plants which comprise the polynucleotide of any one of claims 1-31 and which result from the crossing of plants which have been regenerated from material transformed with the polynucleotide of any one of claims 1-31 or the vector of claim 32, and plants which have been transformed with a polynucleotide comprising regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, desiccation, and herbicides, the progeny of the resultant plants, their seeds and parts.
WO'00/66746 PCT/GB00/01559 N -63-
37. Plants according to either of claims 35 or 36, selected from the group consisting of field crops, fruits and vegetables such as canola, sunflower, tobacco, sugar beet, cotton, maize, wheat, barley, rice, sorghum, tomato, mango, peach, apple, pear, strawberry, banana, melon, potato, carrot, lettuce, cabbage, onion, soya spp, sugar cane, pea, field beans, poplar, grape, citrus, alfalfa, rye, oats, turf and forage grasses, flax and oilseed rape, and nut producing plants insofar as they are not already specifically mentioned, their progeny, seeds and parts.
38. Maize, wheat and rice plants according to any one of claims 35-37.
39. A method of selectively controlling weeds in a field, the field comprising weeds and plants or progeny according to any one of claims 35-38, the method comprising application to the field of a glyphosate type herbicide in an amount sufficient to control the weeds without substantially affecting the plants.
40. A method according to the preceding ¢laim, further comprising application to the field either before or after application of the glyphosate herbicide of one or more of , the following: a herbicide, insecticide, fungicide, nematicide, bacteriocide and an anti-viral.
41. A method of producing plants which are substantially tolerant or substantially resistant to glyphosate herbicide, comprising the steps of: (1) transforming plant material with the polynucleotide of any one of claims 1 to 31 or the vector of claim 32; (it) selecting the thus transformed material; and (iii) ~~ regenerating the thus selected material into morphologically normal fertile whole plants.
42. A method according to the preceding claim, wherein the transformation involves the introduction of the polynucleotide into the material by: (i) biolistic bombardment of the material with particles coated with the polynucleotide; or (ii) impalement of the
-64 - g material on silicon carbide fibres which are coated with a solution comprising the polynucleotide; or (iii) introduction of the polynucleotide or vector into Agrobacterium and co-cultivation of the thus transformed Agrobacterium with plant material which is thereby transformed and is subsequently regenerated.
43. A method according to the preceding claim, wherein the transformed material is selected by its resistance to glyphosate.
44. Use of the polynucleotide of any one of claims 1 to 31, or the vector of claim 32, in the production of plant tissues and/or morphologically normal fertile whole plants which are substantially tolerant or substantially resistant to glyphosate herbicide.
45. Use of the polynucleotide of any one of claims 1 to 31, or the vector of claim 32, in the production of a herbicidal target for the high throughput in vitro screening of potential herbicides.
46. A method of selecting biological material transformed so as to express a gene of interest, wherein the transformed material comprises the polynucleotide of any one of : claims 1 to 31 or the vector of claim 32 and wherein the selection comprises exposing . the transformed material to glyphosate or a salt thereof, and selecting surviving material. :
47. A method according to the preceding claim, wherein the biological material is of plant origin.
48. A method according to the preceding claim, wherein the plant is a monocot.
49. A method according to the preceding claim, wherein the monocot is selected from group consisting of barley, wheat, corn, rice, oats, rye, sorghum, pineapple, sugar cane, banana, onion, asparagus and leek.
50. A method for regenerating a fertile transformed plant to contain foreign DNA comprising the steps of: (a) producing regenerable tissue from said plant to be transformed; (b) transforming said regenerable tissue with said foreign DNA, wherein said foreign DNA comprises a selectable DNA sequence, wherein said sequence functions in a regenerable tissue as a selection device; (©) between about one day to about 60 days after step (b), placing said regenerable tissue from step (b) in a medium capable of producing shoots from said tissue, wherein said medium further contains a compound used to select regenerable tissue containing said selectable DNA sequence to allow identification or selection of the transformed regenerated tissue; (d) after at least one shoot has formed from the selected tissue of step (c) transferring said shoot to a second medium capable of producing roots from said shoot to produce a plantlet, wherein the second medium optionally contains the said compound; and (e) growing said plantlet into a fertile transgenic plant wherein the foreign DNA is transmitted to progeny plants in Mendelian fashion, wherein between step (b) and step (c) there is an optional step of placing the transformed material onto callus } inducing medium, characterised in that the foreign DNA is, or the selectable DNA sequence comprised by the foreign DNA comprises, the polynucleotide according to } any one of claims 1 to 31 or the vector of claim 32, and the said compound is glyphosate or a salt thereof.
51. A method according to the preceding claim, wherein the plant is a monocot selected from the group consisting of banana, wheat, rice, corn and barley.
52. A method according to either of claims 50 or 51, wherein the said regenerable tissue is selected from the group consisting of embryogenic calli, somatic embryos, immature embryos etc.
. L066
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9909971.5A GB9909971D0 (en) | 1999-04-29 | 1999-04-29 | Improvements in or relating to organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200108768B true ZA200108768B (en) | 2003-01-24 |
Family
ID=10852542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200108768A ZA200108768B (en) | 1999-04-29 | 2001-10-24 | Herbicide resistant plants. |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB9909971D0 (en) |
ZA (1) | ZA200108768B (en) |
-
1999
- 1999-04-29 GB GBGB9909971.5A patent/GB9909971D0/en not_active Ceased
-
2001
- 2001-10-24 ZA ZA200108768A patent/ZA200108768B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB9909971D0 (en) | 1999-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6867293B2 (en) | Polynucleotide constructs having at least one transcriptional enhancer and encoding a modified rice EPSPS enzyme | |
US20030049814A1 (en) | Herbicide resistant plants | |
EP1173581A1 (en) | Herbicide resistant plants | |
JP2003528571A6 (en) | Herbicide resistant plants | |
US7169970B2 (en) | Herbicide resistant plants | |
EP1341903B1 (en) | Plant derived hydroxy phenyl pyruvate dioxygneases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases | |
US6143562A (en) | Carbon-based process for selection of transgenic plant cells | |
JP2511036B2 (en) | Glutathione S-transferase gene and herbicide-tolerant plant containing the gene | |
AU2001287862A1 (en) | Herbicide resistant plants | |
JPH11510695A (en) | Induced herbicide resistance | |
JPH03172173A (en) | Sulfonamide resistant gene and its application | |
RU2235778C2 (en) | Isolated polynucleotide able to confer to plant resistance or tolerance to glyfosate herbicide, vector, method for preparing plants with tolerance or resistance to glyfosate herbicide, method for regeneration of transformed plant and method for selective control of weeds | |
ZA200108768B (en) | Herbicide resistant plants. | |
ZA200108766B (en) | Herbicide resistant plants. | |
ZA200108769B (en) | Herbicide resistant plants. | |
CN114585731B (en) | Mutant hydroxyphenylpyruvate dioxygenase polypeptide, encoding gene and application thereof | |
DE60028751T2 (en) | HERBICIDRESISTENT PLANTS | |
ZA200302168B (en) | Herbicide resistant plants. |